
<html lang="en"     class="pb-page"  data-request-id="2aff738d-0c7c-462a-b73a-777e6bcf0f3d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2012.55.issue-9;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm2016107;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Novel 1,2,4-Thiadiazole Derivatives as Potent, Orally Active Agonists of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1)" /></meta><meta name="dc.Creator" content="Feng  Ren" /></meta><meta name="dc.Creator" content="Guanghui  Deng" /></meta><meta name="dc.Creator" content="Hailong  Wang" /></meta><meta name="dc.Creator" content="Linbo  Luan" /></meta><meta name="dc.Creator" content="Qinghua  Meng" /></meta><meta name="dc.Creator" content="Qiongfeng  Xu" /></meta><meta name="dc.Creator" content="Heng  Xu" /></meta><meta name="dc.Creator" content="Xuesong  Xu" /></meta><meta name="dc.Creator" content="Haibo  Zhang" /></meta><meta name="dc.Creator" content="Baowei  Zhao" /></meta><meta name="dc.Creator" content="Chengyong  Li" /></meta><meta name="dc.Creator" content="Taylor B.  Guo" /></meta><meta name="dc.Creator" content="Jiansong  Yang" /></meta><meta name="dc.Creator" content="Wei  Zhang" /></meta><meta name="dc.Creator" content="Yonggang  Zhao" /></meta><meta name="dc.Creator" content="Qiantao  Jia" /></meta><meta name="dc.Creator" content="Hongtao  Lu" /></meta><meta name="dc.Creator" content="Jia-Ning  Xiang" /></meta><meta name="dc.Creator" content="John D.  Elliott" /></meta><meta name="dc.Creator" content="Xichen  Lin" /></meta><meta name="dc.Description" content="A novel series of 1,2,4-thiadiazole compounds was discovered as selective S1P1 agonists. The extensive structure–activity relationship studies for these analogues were reported. Among them, 17g was..." /></meta><meta name="Description" content="A novel series of 1,2,4-thiadiazole compounds was discovered as selective S1P1 agonists. The extensive structure–activity relationship studies for these analogues were reported. Among them, 17g was..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 20, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm2016107" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm2016107" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm2016107" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm2016107" /></link>
        
    
    

<title>Discovery of Novel 1,2,4-Thiadiazole Derivatives as Potent, Orally Active Agonists of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm2016107" /></meta><meta property="og:title" content="Discovery of Novel 1,2,4-Thiadiazole Derivatives as Potent, Orally Active Agonists of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0009.jpeg" /></meta><meta property="og:description" content="A novel series of 1,2,4-thiadiazole compounds was discovered as selective S1P1 agonists. The extensive structure–activity relationship studies for these analogues were reported. Among them, 17g was identified to show high in vitro potency with reasonable free unbound fraction in plasma (Fu &gt; 0.5%), good brain penetration (BBR &gt; 0.5), and desirable pharmacokinetic properties in mouse and rat. Oral administration of 1 mg/kg 17g resulted in significant peripheral lymphocytes reduction at 4 h after dose and rapid lymphocytes recovery at 24 h. 17g showed a transient lymphopenia profile in the repeated dose study in mouse. In addition, 17g also demonstrated efficacy comparable to that of FTY720 (1) in the mouse EAE model of MS." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm2016107"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm2016107">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm2016107&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm2016107&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm2016107&amp;href=/doi/10.1021/jm2016107" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 4286-4296</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3000664" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300095s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Novel 1,2,4-Thiadiazole Derivatives as Potent, Orally Active Agonists of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P<sub>1</sub>)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Feng++Ren">Feng Ren</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guanghui++Deng">Guanghui Deng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hailong++Wang">Hailong Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Linbo++Luan">Linbo Luan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qinghua++Meng">Qinghua Meng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qiongfeng++Xu">Qiongfeng Xu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heng++Xu">Heng Xu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xuesong++Xu">Xuesong Xu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haibo++Zhang">Haibo Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Baowei++Zhao">Baowei Zhao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chengyong++Li">Chengyong Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Taylor+B.++Guo">Taylor B. Guo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiansong++Yang">Jiansong Yang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Zhang">Wei Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yonggang++Zhao">Yonggang Zhao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qiantao++Jia">Qiantao Jia</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongtao++Lu">Hongtao Lu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jia-Ning++Xiang">Jia-Ning Xiang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++Elliott">John D. Elliott</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xichen++Lin">Xichen Lin</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">GlaxoSmithKline, R&D China, No. 3 Building, 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, PRC</span></div><div class="corresp-info"><strong>*</strong>Phone: +86-021-61590718. Fax: +86-021-61590730. E-mail: <a href="/cdn-cgi/l/email-protection#d981b0bab1bcb7f7ebf795b0b799beaab2f7bab6b4"><span class="__cf_email__" data-cfemail="84dcede7ece1eaaab6aac8edeac4e3f7efaae7ebe9">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm2016107&amp;href=/doi/10.1021%2Fjm2016107" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 4286–4296</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 13, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 January 2012</li><li><span class="item_label"><b>Published</b> online</span>20 April 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 May 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm2016107" title="DOI URL">https://doi.org/10.1021/jm2016107</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4286%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFeng%2BRen%252C%2BGuanghui%2BDeng%252C%2BHailong%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D9%26contentID%3Djm2016107%26title%3DDiscovery%2Bof%2BNovel%2B1%252C2%252C4-Thiadiazole%2BDerivatives%2Bas%2BPotent%252C%2BOrally%2BActive%2BAgonists%2Bof%2BSphingosine%2B1-Phosphate%2BReceptor%2BSubtype%2B1%2B%2528S1P1%2529%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4296%26publicationDate%3DMay%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm2016107"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2696</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm2016107" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Novel 1,2,4-Thiadiazole Derivatives as Potent, Orally Active Agonists of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;Ren&quot;},{&quot;first_name&quot;:&quot;Guanghui&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Hailong&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Linbo&quot;,&quot;last_name&quot;:&quot;Luan&quot;},{&quot;first_name&quot;:&quot;Qinghua&quot;,&quot;last_name&quot;:&quot;Meng&quot;},{&quot;first_name&quot;:&quot;Qiongfeng&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Heng&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Xuesong&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Haibo&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Baowei&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Chengyong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Taylor&quot;,&quot;last_name&quot;:&quot;B. Guo&quot;},{&quot;first_name&quot;:&quot;Jiansong&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Yonggang&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Qiantao&quot;,&quot;last_name&quot;:&quot;Jia&quot;},{&quot;first_name&quot;:&quot;Hongtao&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Jia-Ning&quot;,&quot;last_name&quot;:&quot;Xiang&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. Elliott&quot;},{&quot;first_name&quot;:&quot;Xichen&quot;,&quot;last_name&quot;:&quot;Lin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;4286-4296&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm2016107&quot;},&quot;abstract&quot;:&quot;A novel series of 1,2,4-thiadiazole compounds was discovered as selective S1P1 agonists. The extensive structure–activity relationship studies for these analogues were reported. Among them, 17g was identified to show high in vitro potency with reasonable free unbound fraction in plasma (Fu &gt; 0.5%), good brain penetration (BBR &gt; 0.5), and desirable pharmacokinetic properties in mouse and rat. Oral administration of 1 mg/kg 17g resulted in significant peripheral lymphocytes reduction at 4 h after dose and rapid lymphocytes recovery at 24 h. 17g showed a transient lymphopenia profile in the repeated dose study in mouse. In addition, 17g also demonstrated efficacy comparable to that of FTY720 (1) in the mouse EAE model of MS.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2016107&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016107" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2016107&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016107" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2016107&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016107" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm2016107&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016107&amp;href=/doi/10.1021/jm2016107" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm2016107" /></input><a href="/doi/pdf/10.1021/jm2016107" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (857 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm2016107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm2016107%26sid%3Dliteratum%253Aachs%26pmid%3D22500954%26genre%3Darticle%26aulast%3DRen%26date%3D2012%26atitle%3DDiscovery%2Bof%2BNovel%2B1%252C2%252C4-Thiadiazole%2BDerivatives%2Bas%2BPotent%252C%2BOrally%2BActive%2BAgonists%2Bof%2BSphingosine%2B1-Phosphate%2BReceptor%2BSubtype%2B1%2B%2528S1P1%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D9%26spage%3D4286%26epage%3D4296%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jmcmar.2012.55.issue-9/production/jmcmar.2012.55.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel series of 1,2,4-thiadiazole compounds was discovered as selective S1P<sub>1</sub> agonists. The extensive structure–activity relationship studies for these analogues were reported. Among them, <b>17g</b> was identified to show high in vitro potency with reasonable free unbound fraction in plasma (<i>F</i><sub>u</sub> > 0.5%), good brain penetration (BBR > 0.5), and desirable pharmacokinetic properties in mouse and rat. Oral administration of 1 mg/kg <b>17g</b> resulted in significant peripheral lymphocytes reduction at 4 h after dose and rapid lymphocytes recovery at 24 h. <b>17g</b> showed a transient lymphopenia profile in the repeated dose study in mouse. In addition, <b>17g</b> also demonstrated efficacy comparable to that of FTY720 (<b>1</b>) in the mouse EAE model of MS.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65611" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65611" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Multiple sclerosis (MS) is a debilitating, progressive autoimmune disorder in the CNS as a result of inflammation mediated neural cell damage.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> As the leading cause of neurological disability and impairment in young adults (aged 20–40 years), MS is believed to affect around 2.5 million individuals worldwide.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Most MS patients (∼85%) are diagnosed with the relapsing–remitting form of the disease.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Currently, all available drugs on the market are administered by injection except for fingolimod (FTY720, <b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which was recently approved as the first oral drug for RRMS.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of FTY720 (<b>1</b>) and its phosphate (<b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The therapeutic activity of <b>1</b> could be mainly due to its ability to reduce lymphocyte infiltration into CNS by sequestration of peripheral T-cells and B-cells in secondary lymphoid organs.<a onclick="showRef(event, 'ref3 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref5">(3, 5)</a> In addition, <b>1</b> may act directly on neural cells to enhance remyelination in cerebellar slices with lysolecithin-induced demyelination<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and to attenuate astrogliosis in animal models of MS.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The pharmacological efficacy of <b>1</b> is believed to result from the agonism activity of its monophosphate metabolite (FTY720-p, <b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) to S1P<sub>1</sub>,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> a G-protein-coupled receptor that regulates peripheral lymphocyte trafficking<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and affects neural cell survival.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> S1P<sub>1</sub> receptor has then emerged as an attractive molecular target for the discovery of new therapeutic agents for autoimmune diseases.</div><div class="NLM_p"><b>2</b> is a nonselective S1P<sub>1</sub> agonist over the other S1P receptors (S1P<sub>3</sub>, S1P<sub>4</sub>, and S1P<sub>5</sub>),<a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">(8b)</a> and agonism of S1P<sub>3</sub> is thought to be related to hemodynamic and pulmonary side effects seen in clinical trials.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Thus, clinical compounds were optimized toward S1P<sub>1</sub> agonists with increased selectivity over S1P<sub>3</sub>, including prodrug 2-amino-2-[2-[2-chloro-4-[[3-(phenylmethoxy)phenyl]thio]phenyl]ethyl]-1,3-propanediol hydrochloride (KRP-203),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> as well as direct S1P<sub>1</sub> agonists (<i>E</i>)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic acid (BAF312, proposed structure)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and (<i>Z</i>,<i>Z</i>)-5-[3-chloro-4-((2R)-2,3-dihydroxypropoxy)benzylidene]-2-propylimino-3-<i>o</i>-tolylthiazolidin-4-one (ACT128800).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">There have been extensive SAR studies on structurally diverse S1P<sub>1</sub> receptor agonists reported to date,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> among which oxadiazole derivatives were demonstrated to be potent and selective S1P<sub>1</sub> receptor agonists with good pharmacokinetic properties.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Most recently, a novel class of oxadiazole analogues were discovered from this laboratory as selective S1P<sub>1</sub> receptor agonists that showed efficacy comparable to that of <b>1</b> in the mouse EAE model, an animal model for multiple sclerosis, by oral dosing (<b>3</b> as a representative, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> However, there were several issues associated with this compound that potentially can delay its clinical development. Even though compound <b>3</b> showed reasonable CNS penetration (BBR > 0.5), its high protein binding (<i>F</i><sub>u</sub> = 0.04%)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> indicates a low free drug concentration in the brain. In addition, the literature-reported opening of the oxadiazole ring under certain circumstances was also a concern to us with regard to further development of compound <b>3</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Thus, a more stable compound with high CNS penetration balanced with reasonable plasma protein binding should be developed. Herein, we report the discovery of a novel 1,2,4-thiadiazole series as potent, orally active S1P<sub>1</sub>  agonists with improved plasma protein binding (<i>F</i><sub>u</sub> > 0.5%) and high CNS penetration (BBR > 0.5) for the treatment of MS.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lead compound <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We first turned our attention to the replacement of the oxadiazole core by other aromatics/heteroaromatics to improve its stability. The opening potential of the oxadiazole ring could be represented by its low aromatic index (AI, 39 for oxadiazole and 100 for benzene), an indication of aromaticity of five- or six-membered ring heterocycles.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Thus, analogues containing different heterocyclic aromatic cores with higher aromaticity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, AI > 45) were synthesized and evaluated in the in vitro S1P<sub>1</sub> assay. Even though all 21 cores synthesized (<b>4a</b>–<b>u</b>) showed reduced S1P<sub>1</sub> receptor agonism activities in the cell based FRET assay,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> quite a few of them demonstrated reasonable potency (<b>4a</b>–<b>g</b>, <b>4l</b>, and <b>4m</b>) with pEC<sub>50</sub> > 8.0. We then further evaluated these compounds for their physicochemical and biological properties in order to prioritize the chemical series for further SAR studies (<b>4g</b> was excluded because of its low AI).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. S1P<sub>1</sub> Potencies with Different Aromatic/Heteroaromatic Cores</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0003.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0004.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Data are the average of at least two determinations.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">AI data are from ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a>.</p></div></div><div></div></div><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, these compounds should have cores more stable than the 1,2,4-oxadiazole core, as indicated by their AI (all >50, compared to 39 of 1,2,4-oxadiazole). They are all selective S1P<sub>1</sub> receptor agonists over S1P<sub>3</sub> (pEC<sub>50</sub> < 5)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> with good permeability and solubility properties. None of them raised drug–drug interaction concerns, as evidenced by their lack of to low inhibitory activities against CYP enzymes (2C9, 2C19, 2D6, and 3A4). However, the compound with the 1,3,4-oxadiazole core (<b>4d</b>) showed low CNS penetration property (mouse, ip dosing) with BBR of 0.11 and 0.09 at 1 and 4 h, respectively. Since the brain exposure is critical for a CNS drug, <b>4d</b> is thus deprioritized from further progress. On the other hand, analogues with the thiophene and phenyl cores (<b>4f</b> and <b>4l</b>) are highly brain penetrable (BBR > 0.9 at both 1 and 4 h), whereas their developability was predicted to be poor (cLogP = 7.3) according to Lipinski’s rule.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> For this reason, <b>4f</b> and <b>4l</b> were also deprioritized. It is noteworthy that most of the compounds (except for <b>4a</b>) showed high protein binding property. We decided to resolve this issue at a later stage, knowing several strategies are available in literature to improve protein binding.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> For further comparison, the four compounds with the 1,3,4-thiadiazole core (<b>4a</b>), the 1,2,4-thiadiazole core (<b>4b</b>), the thiazole core (<b>4e</b>), and the pyrimidine core (<b>4m</b>) were progressed to in vivo studies.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Physicochemical and Biological Properties of Compounds <b>3</b>, <b>4a</b>, <b>4b</b>, <b>4d</b>, <b>4e</b>, <b>4f</b>, <b>4l</b>, and <b>4m</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">AI<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">S1P<sub>1</sub></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub></th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">permeability (nm/s)</th><th class="colsep0 rowsep0" align="center">solubility (μg/mL)</th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub>(P450)</th><th class="colsep0 rowsep0" align="center"><i>F</i><sub>u</sub> (%) (human)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">BBR (1 h)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">BBR (4 h)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">9.7</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">345</td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">all <5<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.04*</td><td class="colsep0 rowsep0" align="left">0.53</td><td class="colsep0 rowsep0" align="left">0.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">8.9</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">230</td><td class="colsep0 rowsep0" align="left">256</td><td class="colsep0 rowsep0" align="left">all <5<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.51</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">8.6</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">320</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">5.3 (2C9)</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.36</td><td class="colsep0 rowsep0" align="left">0.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">240</td><td class="colsep0 rowsep0" align="left">187</td><td class="colsep0 rowsep0" align="left">5.1 (2C9)</td><td class="colsep0 rowsep0" align="left">0.21*</td><td class="colsep0 rowsep0" align="left">0.11</td><td class="colsep0 rowsep0" align="left">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">6.1</td><td class="colsep0 rowsep0" align="left">220</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">5.4 (2C9)</td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.38</td><td class="colsep0 rowsep0" align="left">0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4f</b></td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">8.4</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">300</td><td class="colsep0 rowsep0" align="left">115</td><td class="colsep0 rowsep0" align="left">5.8 (2C9)</td><td class="colsep0 rowsep0" align="left">0.02*</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4l</b></td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">310</td><td class="colsep0 rowsep0" align="left">154</td><td class="colsep0 rowsep0" align="left">5.4 (2C9)</td><td class="colsep0 rowsep0" align="left">0.01*</td><td class="colsep0 rowsep0" align="left">0.93</td><td class="colsep0 rowsep0" align="left">0.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4m</b></td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">161</td><td class="colsep0 rowsep0" align="left">5.2 (2D6)</td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">0.48</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">S1P<sub>1</sub>, S1P<sub>3</sub> assay data are the average of at least two determinations.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">AI data are from ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a>.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">All >5 except for the five CYP enzymes that were included in the assay panel: 1A2, 2D6, 2C9, 2C19, and 3A4.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last"><i>F</i><sub>u</sub> in human plasma unless otherwise indicated by an asterisk; (∗) <i>F</i><sub>u</sub> in rat plasma.</p></div></div></div><div class="NLM_p">Mouse pharmacokinetic studies for the four compounds revealed a desirable PK profile (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). They all had good oral bioavailability (>75%), moderate to long half-lives (1.5–8.0 h), and moderate to high blood exposure (2.60–11.5 μg·h/mL). Thus, all compounds were suitable for further evaluation in in vivo pharmacological studies. It is well established that S1P<sub>1</sub> agonism causes lymphocyte retention in the secondary lymphoid organs, leading to rapid onset of lymphopenia. In the acute mouse lymphopenia model where the number of peripheral blood lymphocytes was measured at 4 and 24 h after a single oral administration (<a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>), these compounds (1 mg/kg) caused a pharmacologically relevant lymphocyte reduction to 15–38% of baseline levels at 4 h, along with rapid recovery in lymphocytes counts (88%, 63%, and 103% of baseline lymphocyte levels by 24 h for <b>4b</b>, <b>4e</b>, and <b>4m</b>, respectively; <b>4a</b> showed sustained lymphopenia effect with <44% lymphocyte recovery). These compounds were further evaluated in the mouse EAE model.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> At a daily oral dose of 1 mg/kg starting from disease onset (indicated by a nonzero mean clinical score), compounds <b>4b</b> and <b>4m</b> demonstrated efficacy comparable to that of <b>1</b> (1 mg/kg) (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). Compounds <b>4a</b> and <b>4e</b>, however, showed no/marginal beneficial effect in the EAE model (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a and Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). Thus, the 1,2,4-thiadiazole series (<b>4b</b>) and the pyrimidine series (<b>4m</b>), which demonstrated efficacy in both lymphopenia and EAE models, were selected for further structure–activity relationship studies. In this paper, we will focus on the 1,2,4-thiadiazole series because of space limitation.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0013.jpeg" id="GRAPHIC-d918e1013-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Treatment efficacy of compound <b>4a</b> in mouse EAE. (b) Treatment efficacy of compounds <b>4b</b>, <b>4e</b>, and <b>4m</b> in mouse EAE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Mouse Pharmacokinetic and Lymphopenia Studies for Compounds <b>4a</b>, <b>4b</b>, <b>4e</b>, and <b>4m</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">mouse PK</th><th class="colsep0 rowsep0" align="center">lymphocyte counts (relative to baseline)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> = 3.8 h; <i>F</i> ≈ 100%</td><td class="colsep0 rowsep0" align="left">37.9% (4 h),</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>0–24h</sub> = 5.94 μg·h/mL</td><td class="colsep0 rowsep0" align="left">43.6% (24 h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> = 1.5 h; <i>F</i> = 87%</td><td class="colsep0 rowsep0" align="left">22.7% (4 h),</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>0–24h</sub> = 2.60 μg·h/mL</td><td class="colsep0 rowsep0" align="left">87.9% (24 h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> = 3.6 h; <i>F</i> ≈ 100%</td><td class="colsep0 rowsep0" align="left">15.3% (4 h),</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>0–24h</sub> = 8.34 μg·h/mL</td><td class="colsep0 rowsep0" align="left">62.6% (24 h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4m</b></td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> = 8.0 h; <i>F</i> = 78%</td><td class="colsep0 rowsep0" align="left">34.9% (4 h),</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>0–24h</sub> = 11.5 μg·h/mL</td><td class="colsep0 rowsep0" align="left">103.2% (24 h)</td></tr></tbody></table></div></div><div class="NLM_p">We first examined the effects of substitutions on the left-hand side aromatic group of <b>4b</b> on the S1P<sub>1</sub> receptor potency (<b>4b</b>–<b>5h</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Replacements of the cyano group of <b>4b</b> with either chlorine (<b>5a</b>) or trifluoromethyl (<b>5b</b>) substitutions retained potency. The isopropoxyl group could also be replaced by the isobutyl (<b>5c</b>) functionality with similar or increased potency. A slight decrease of S1P<sub>1</sub> agonist activity was observed once an N atom was introduced to the phenyl ring (<b>5d</b>). The replacement of the isopropoxyl functionality was tolerated with the phenyl ring (<b>5h</b>) or an electron-donating piperidine group (<b>5g</b>), compared to <b>5b</b>. However, when more heteroatoms (O or N) were introduced to the piperidine ring, a significant decrease of S1P<sub>1</sub> potency was observed (<b>5e</b> and <b>5f</b>). SAR for substitutions on the left-hand aromatic ring suggested that isopropoxyl and isobutyl groups are preferred at the para position and cyano, chloro, and trifluoromethyl functionalities are preferred at the meta position. As mentioned previously, one problem of the 1,2,4-thiadiazole series is their high plasma protein binding (<i>F</i><sub>u</sub> of 0–0.32% for <b>4b</b>–<b>5h</b>), which may contribute to the disconnection between the in vitro potency and the in vivo efficacy. A well-established solution to improve the protein binding is to introduce polarity to the molecule. We first tried to introduce an N atom to the right-hand aromatic ring (<b>5i</b>–<b>l</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). However, this led to a significant decrease in the S1P<sub>1</sub> receptor potency (S1P<sub>1</sub> pEC<sub>50</sub> of 6.4–7.6) without any significant improvement in plasma protein binding (<i>F</i><sub>u</sub> of 0.12–0.19% for <b>5i</b>–<b>l</b>). We then turned our attention to introduce polarity (such as N) to the carboxylic side chain for better potency and plasma protein binding.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of the Left-Hand and Right-Hand Aromatic Rings and the Human Plasma Protein Binding Data Measured as <i>F</i><sub>u</sub></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0005.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0006.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Data are the average of at least two determinations.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last"><i>F</i><sub>u</sub> in human plasma unless otherwise indicated by an asterisk; (∗) <i>F</i><sub>u</sub> in rat plasma.</p></div></div><div></div></div><div class="NLM_p">In order to efficiently explore the SAR of the carboxylic acid side chain, convergent syntheses of the general structures <b>12</b> and <b>17</b> were developed, where the diversity (amino acid side chains) was introduced at the last step (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Suzuki coupling of the commercially available starting material 5-chloro-3-bromo-1,2,4-thiadiazole (<b>6</b>) with boronic ester <b>7</b> provided diaryl bromide <b>8</b>. The second Suzuki coupling of <b>8</b> with boronic ester <b>9</b> afforded aldehyde <b>10</b>. The final step of the reductive amination with different amino acids <b>11</b> gave benzylic amino acid analogues <b>12</b> with generally acceptable yield. For the synthesis of homobenzylic amino acid derivatives, the boronic ester for the second Suzuki coupling is methyl enoether <b>13</b>. After acid catalyzed hydrolysis of the methyl enoether <b>14</b>, aldehyde <b>15</b> was obtained with a moderate to good yield. Reductive amination then afforded homobenzylic amino acid derivatives <b>17</b>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedure for the 1,2,4-Thiadiazole Amino Acid Derivatives <b>12</b> and <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <b>7</b>, PdCl<sub>2</sub>(dppf), K<sub>3</sub>PO<sub>4</sub>, 53–97%. (b) <b>9</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, 77–94%. (c) <b>11</b>, NaBH(OAc)<sub>3</sub>, HOAc, 10–60%. (d) <b>13</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, 65–98%. (e) HCl, 80–100%. (f) <b>16</b>, NaBH(OAc)<sub>3</sub>, HOAc, 10–60%.</p></p></figure><div class="NLM_p">Having developed a robust synthetic procedure for various amino acid analogues, we started to investigate the right side of SAR. Trifluoromethyl substitution on the left-hand phenyl ring was our first focus (<b>12a</b>–<b>d</b> and <b>17a</b>–<b>d</b>) because of the higher potency. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, straight chain benzylic amino acid derivatives (<b>12a</b> and <b>12b</b>) showed moderate S1P<sub>1</sub> agonist activities. Extending the side chain by one carbon to homobenzylic amino acid analogues provided much improved potency (<b>17a</b> and <b>17b</b>). Cyclic amino acids resulted in either similar or higher potency (<b>12c</b> and <b>12d</b>, respectively). Further extending the side chain to their homobenzylic analogues led to a substantial increase of activity (piperidine analogue <b>17c</b>) or a similar activity (azetidine analogue <b>17d</b>). However, these compounds (<b>12a</b>–<b>d</b> and <b>17a</b>–<b>d</b>) still showed high protein binding except for <b>12a</b>. Apparently, a further lipophilicity reduction of these compounds is needed. We then turned our attention to replace the trifluoromethyl group with less lipophilic Cl and CN. As the straight chain amino acid derivatives provided limited exposure probably because of high clearance, the cyclic amino acid analogues were chosen to be explored. As expected, replacement of the trifluoromethyl group with Cl (<b>12e</b>, <b>17e</b>, and <b>17f</b>) or CN (<b>12f</b>, <b>17g</b>, and <b>17h</b>) resulted in much improved protein binding property with <i>F</i><sub>u</sub> at 0.45–1.28%. In addition, all of them showed excellent S1P<sub>1</sub> potency (pEC<sub>50</sub> > 9.0) except for the two benzylic azetidine derivatives (<b>12e</b> and <b>12f</b>). The carboxylic acid functionality proved to be critical for S1P<sub>1</sub> activity. Replacement or removal of the carboxylic acid resulted in dramatic decrease in potency (<b>17i</b> and <b>17j</b>). All compounds (<b>12a</b>–<b>f</b> and <b>17a</b>–<b>h</b>) proved to be selective S1P<sub>1</sub> receptor agonists versus S1P<sub>3</sub> (>1000 fold). Among these compounds, <b>17e</b> and <b>17g</b> demonstrated good overall balanced profile (S1P<sub>1</sub> pEC<sub>50</sub> > 9.0; <i>F</i><sub>u</sub> > 0.4%; BBR > 0.5, Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) and were then selected for further in vitro and in vivo evaluation.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR for Amino Acid Side Chains<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0007.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0008.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">S1P<sub>1</sub>, S1P<sub>3</sub> assay data are the average of at least two determinations.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last"><i>F</i><sub>u</sub> in human plasma unless otherwise indicated by an asterisk; (∗) <i>F</i><sub>u</sub> in rat plasma.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro and in Vivo Data for <b>17e</b> and <b>17g</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>17e</b></th><th class="colsep0 rowsep0" align="center"><b>17g</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BBR<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.52 (1 h)</td><td class="colsep0 rowsep0" align="left">0.23 (1 h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.48 (4 h)</td><td class="colsep0 rowsep0" align="left">0.65 (4 h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse PK</td><td class="colsep0 rowsep0" align="left"><i>F</i><sub>po</sub> = 40%</td><td class="colsep0 rowsep0" align="left"><i>F</i><sub>po</sub> = 45%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> = 15.6 h</td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> = 5.3 h</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat PK<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><i>F</i><sub>po</sub> = 70%</td><td class="colsep0 rowsep0" align="left"><i>F</i><sub>po</sub> = 50%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> = 27.7 h</td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> = 6.2 h</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lymphopenia<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">16% (4 h),</td><td class="colsep0 rowsep0" align="left">23% (4 h),</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">40% (24 h)</td><td class="colsep0 rowsep0" align="left">72% (24 h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP (1A2, 2D6, 2C9, 2C19, 3A4)</td><td class="colsep0 rowsep0" align="left">all pIC<sub>50</sub> < 5</td><td class="colsep0 rowsep0" align="left">all pIC<sub>50</sub> < 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSH conjugates</td><td class="colsep0 rowsep0" align="left">not observed</td><td class="colsep0 rowsep0" align="left">not observed</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Male Sprague–Dawley (for iv, 1 mg/kg, 1%DMSO in 10% HP-β-CD (w/v), <i>N</i> = 3; for po, 2 mg/kg, 1% DMSO in 1% MC (w/v), <i>N</i> = 3).</p></div></div></div><div class="NLM_p">In a mouse CNS penetration study, both <b>17e</b> and <b>17g</b> showed good BBR (1.49 and 0.68, respectively, at 4 h after dosing; Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Mouse PK studies revealed that both compounds had decent oral bioavailability (∼40%) and moderate to long half-lives (15.6 and 5.3 h for <b>17e</b> and <b>17g</b>, respectively). In rat, <b>17e</b> also showed a much longer half-life (27.7 h) than <b>17g</b> (6.2 h). Again, both compounds demonstrated good bioavailability (>50%) in rat. Encouraged by their mouse and rat PK profile, we evaluated both compounds in in vivo efficacy studies. In the acute mouse lymphopenia model, both compounds turned out to be efficacious at 1 mg/kg (62–83% lymphocyte reduction at 4 h). On the basis of the lymphocyte counts measured by 24 h, compound <b>17g</b> (72% of baseline at 24 h) had a transient effect whereas compound <b>17e</b> resulted in a sustained lymphopenia profile (only 40% of baseline at 24 h). Thus, duration of the PD effect produced by these compounds seemed to correlate with their half-lives. As expected, both compounds demonstrated good stability and no glutathione (GSH) adducts were observed in the GSH conjugation study. Neither compound showed inhibitory activity in the human CYP enzymes (1A2, 2D6, 2C9, 2C19, and 3A4), indicating that there is no drug–drug interaction concern. They were both progressed to the chronic mouse EAE evaluation. To our delight, both compounds were efficacious at a daily oral dose of 1 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0014.jpeg" id="GRAPHIC-d918e1792-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Treatment efficacy of compound <b>17e</b> in mouse EAE. (b) Treatment efficacy of compound <b>17g</b> in mouse EAE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>17g</b> was further progressed in both single and repeat dosing lymphopenia studies to assess its PK–PD relationship to facilitate human dose selection. The single dose rat PK–PD study demonstrated a dose-dependent lymphocyte reduction and later on reversal over a 60 h period (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a), with a calculated IC<sub>50</sub> of 12 ng/mL. In addition, the repeat-dose study showed that at the EAE-efficacious dose of 1 mg/kg, compound <b>17g</b> rapidly produced a daily lymphocyte reduction at the range 20–60% of baseline over the treatment period (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b). Perhaps more important, lymphocyte counts recovered to normal range (∼70% of baseline) 3 days after treatment cessation.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0001.jpeg" id="GRAPHIC-d918e1820-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Dose-dependent lymphopenia produced by single ascending dose of compound <b>17g</b>. (b) Chronic lymphopenia elicited by repeat dosing of compound <b>17g</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have discovered a novel 1,2,4-thiadiazole series of compounds as selective S1P<sub>1</sub> agonists. Extensive SAR studies led to the discovery of compound <b>17g</b>, a potent S1P<sub>1</sub> agonist (pEC<sub>50</sub> > 9) with reasonable <i>F</i><sub>u</sub> in plasma (0.64%), good brain penetration (BBR > 0.5), and desirable PK properties in rodent species. Oral administration of 1 mg/kg of <b>17g</b> resulted in significant peripheral lymphocyte reduction at 4 h after dose and rapid lymphocyte recovery at 24 h. A transient lymphopenia profile for <b>17g</b> was observed in the repeat dosing lymphopenia study. In addition, <b>17g</b> demonstrated comparable efficacy to <b>1</b> in the mouse EAE model of MS.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Chemistry</h3><div class="NLM_p">Compounds not described below were purchased from commercial vendors or as previously reported. Compound purity was determined using LC/MS analysis. Purification of the compounds was carried out by conventional methods such as chromatography and/or recrystallization using suitable solvents. Chromatographic methods include column chromatography, flash chromatography, and MDAP (mass directed autopurification system).</div><div class="NLM_p last"><sup>1</sup>H NMR spectral data were recorded on a Bruker 400 NMR spectrometer operating at 400 MHz. <sup>13</sup>C NMR spectra were recorded at 100 MHz. CDCl<sub>3</sub> is deuteriochloroform, and DMSO-<i>d</i><sub>6</sub> is hexadeuteriodimethylsulfoxide. Chemical shifts are given in parts per million (δ) downfield from the internal standard tetramethylsilane (TMS) or the NMR solvent. Abbreviations for NMR data are as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = doublet of doublets, dt = doublet of triplets, app = apparent, br = broad. <i>J</i> indicates the NMR coupling constant measured in hertz. High resolution mass spectrometry (HRMS) was operated in positive mode of electrospray ionization (ESI) at an orthogonal acceleration time-of-flight (oa-TOF) SYNAPT G2 HDMSTM (Waters, Manchester, U.K.). Solutions (500 ng/mL in ACN/H<sub>2</sub>O (1:1, v/v)) were introduced via infusion at a flow rate of 5 μL/min to acquire accurate mass. LC/MS (Agilent 1200SL-6110) analysis was conducted for all assayed compounds in either acidic or basic conditions. (1) Acidic conditions refer to water containing 0.05% TFA/acetonitrile as mobile phase on an Agilent SB-C18 column (1.8 μm, 4.6 mm × 30 mm) with MS instrument and photodiode array detector. The following conditions were used: a gradient from 5% to 95% in 4 min (or 6 min) and held at 95% for 1 min; UV detection at 214 and 254 nm; a flow rate of 1.5 mL/min; full scan; mass range from 100 to 1000 amu. (2) Basic conditions refer to water containing 10 mM aqueous NH<sub>4</sub>HCO<sub>3</sub>/acetonitrile as mobile phase on a Waters XBridge C18 column (3.5 μm, 4.6 mm × 50 mm) with MS instrument and photodiode array detector. The following conditions were used: a gradient from 5% to 95% in 5 min and held at 95% for 1 min; UV detection at 214 and 254 nm; a flow rate of 2 mL/min; full scan; mass range from 100 to 1000 amu. All the assayed compounds possess ≥95% purity determined using LC/MS analysis. Column chromatography was performed on Isco or Biotage instrument using a prepacked silica gel column, a detector with UV wavelength at 254 nm, and mixed solvents. MDAP equipped with 2489 UV detector, 2767 sample manager, 2545 pump, and 3100 single quadrupole mass spectrometer was performed on Sunfire Prep C18 column (5 μm, 19 mm × 50 mm) using water containing 0.05% TFA/acetonitrile as mobile phase. The following conditions were used: a gradient from 5% to 95% in 8 min and held in 95% for 2 min; a flow rate of 30 mL/min.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 3-Bromo-5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazole (<b>8a</b>)</h3><div class="NLM_p last">To a solution of 2-(3-chloro-4-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane <b>7a</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (500 mg, 1.51 mmol), 3-bromo-5-chloro-1,2,4-thiadiazole <b>6</b> (604 mg, 3.03 mmol), and tripotassium phosphate (964 mg, 4.54 mmol) in DMF (3 mL) and water (0.6 mL) was added PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub> adduct (618 mg, 0.76 mmol). The vessel was sealed and heated in a microwave reactor at 80 °C for 1 h. After cooling, the mixture was concentrated in vacuo, and the residue was purified by chromatography on silica gel with petroleum/ethyl acetate (4:1) to give 294 mg (53%) of <b>8a</b> as a white solid. ESMS <i>m</i>/<i>z</i>: 366.9 (M + H)<sup>+</sup>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 3-Bromo-5-(3-chloro-4-isopropoxyphenyl)-1,2,4-thiadiazole (<b>8b</b>)</h3><div class="NLM_p last">Compound <b>8b</b> (6.2 g, 66%) was prepared from 2-(3-chloro-4-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane <b>7b</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (6 g, 28 mmol) and <b>6</b> (11.2 g, 56 mmol) in the same manner as described for <b>8a</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 1.44 (d, <i>J</i> = 6.40 Hz, 6 H), 4.69 (dt, <i>J</i> = 12.05, 6.40 Hz, 1 H), 7.01 (d, <i>J</i> = 8.66 Hz, 1 H), 7.78 (dd, <i>J</i> = 8.28, 2.26 Hz, 1 H), 7.99 (d, <i>J</i> = 2.26 Hz, 1 H). ESMS <i>m</i>/<i>z</i>: 333.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 5-(3-Bromo-1,2,4-thiadiazol-5-yl)-2-isobutylbenzonitrile (<b>8c</b>)</h3><div class="NLM_p last">Compound <b>8c</b> (1.14 g, 88%) was prepared from 2-(2-methylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile <b>7c</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (1 g, 3.51 mmol) and <b>6</b> (1.399 g, 7.01 mmol) in the same manner as described for <b>8a</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 1.00 (d, <i>J</i> = 6.78 Hz, 6 H), 2.01–2.10 (m, 1 H), 2.81 (d, <i>J</i> = 7.53 Hz, 2 H), 7.47 (d, <i>J</i> = 8.28 Hz, 1 H), 8.06 (dd, <i>J</i> = 8.28, 1.88 Hz, 1 H), 8.23 (d, <i>J</i> = 1.88 Hz, 1 H). ESMS <i>m</i>/<i>z</i>: 321.9 (M + H)<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-Ethyl-3-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-3-yl)benzaldehyde (<b>10a</b>)</h3><div class="NLM_p last">To a solution of <b>8a</b> (0.93 g, 2.53 mmol) in DMF (6 mL) and water (1.5 mL) were added 2-ethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde <b>9</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (0.659 g, 2.53 mmol), tripotassium phosphate (1.344 g, 6.33 mmol), and Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.585 g, 0.507 mmol). The reaction vessel was sealed and heated with a microwave reactor at 120 °C for 15 min. After cooling, the reaction mixture was filtered and the solid was washed with ethyl acetate (2 × 15 mL). The filtrate and the washing solution were combined. The combined solution was washed with water (2 × 20 mL), then dried over anhydrous sodium sulfate. The dried solution was concentrated in vacuo, and the residue was purified by chromatography on silica gel with petroleum/ethyl acetate (9:1) to give 1 g (94%) of <b>10a</b> as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.37 (t, <i>J</i> = 7.40 Hz, 3 H), 1.44 (d, <i>J</i> = 6.02 Hz, 6 H), 3.39 (q, <i>J</i> = 7.40 Hz, 2 H), 4.78 (dt, <i>J</i> = 12.11, 6.02 Hz, 1 H), 7.14 (d, <i>J</i> = 8.78 Hz, 1 H), 7.50 (t, <i>J</i> = 7.78 Hz, 1 H), 8.02 (dd, <i>J</i> = 7.78, 1.51 Hz, 1 H), 8.12–8.17 (m, 2 H), 8.24 (d, <i>J</i> = 2.01 Hz, 1 H), 10.48 (s, 1 H). ESMS <i>m</i>/<i>z</i>: 421.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 3-(5-(3-Chloro-4-isopropoxyphenyl)-1,2,4-thiadiazol-3-yl)-2-ethylbenzaldehyde (<b>10b</b>)</h3><div class="NLM_p last">Compound <b>10b</b> (450 mg, 78%) was prepared from <b>8b</b> (500 mg, 1.51 mmol) and <b>9</b> (390 mg, 1.51 mmol) in the same manner as described for <b>10a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.37 (t, <i>J</i> = 7.40 Hz, 3 H), 1.45 (d, <i>J</i> = 6.02 Hz, 6 H), 3.38 (q, <i>J</i> = 7.40 Hz, 2 H), 4.71 (dt, <i>J</i> = 12.11, 6.02 Hz, 1 H), 7.05 (d, <i>J</i> = 8.78 Hz, 1 H), 7.49 (t, <i>J</i> = 7.65 Hz, 1 H), 7.88 (dd, <i>J</i> = 8.53, 2.26 Hz, 1 H), 8.01 (dd, <i>J</i> = 7.65, 1.38 Hz, 1 H), 8.08 (d, <i>J</i> = 2.01 Hz, 1 H), 8.14 (dd, <i>J</i> = 7.78, 1.51 Hz, 1 H), 10.48 (s, 1 H). ESMS <i>m</i>/<i>z</i>: 387.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 5-(3-(2-Ethyl-3-formylphenyl)-1,2,4-thiadiazol-5-yl)-2-isobutylbenzonitrile (<b>10c</b>)</h3><div class="NLM_p last">Compound <b>10c</b> (520 mg, 89%) was prepared from <b>8c</b> (500 mg, 1.55 mmol) and <b>9</b> (424 mg, 1.63 mmol) in the same manner as described for <b>10a</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 1.01 (d, <i>J</i> = 6.78 Hz, 6 H), 1.38 (t, <i>J</i> = 7.34 Hz, 3 H), 2.03–2.10 (m, 1 H), 2.82 (d, <i>J</i> = 7.53 Hz, 2 H), 3.40 (q, <i>J</i> = 7.34 Hz, 2 H), 7.47–7.54 (m, 2 H), 8.04 (d, <i>J</i> = 7.53 Hz, 1 H), 8.12–8.19 (m, 2 H), 8.31 (d, <i>J</i> = 1.88 Hz, 1 H), 10.48 (s, 1 H). ESMS <i>m</i>/<i>z</i>: 376.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-((2-Ethyl-3-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-3-yl)benzyl)(methyl)amino)acetic Acid (<b>12a</b>)</h3><div class="NLM_p last">To a solution of <b>10a</b> (80 mg, 0.19 mmol) in DCM (6 mL) were added <i>N</i>-methylglycine (51 mg, 0.57 mmol) and acetic acid (0.022 mL, 0.38 mmol). The reaction solution was stirred at room temperature overnight. Sodium triacetoxyborohydride (81 mg, 0.38 mmol) was added, and stirring continued for another 2 h. The reaction mixture was concentrated in vacuo, and the residue was purified by MDAP to give 35 mg (30%) of <b>12a</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.09 (t, <i>J</i> = 7.28 Hz, 3 H), 1.34 (d, <i>J</i> = 6.02 Hz, 6 H), 2.74 (s, 3 H), 3.08 (q, <i>J</i> = 7.28 Hz, 2 H), 4.11 (s, 2 H), 4.42 (s, 2 H), 4.96 (dt, <i>J</i> = 11.98, 6.02 Hz, 1 H), 7.47 (t, <i>J</i> = 7.65 Hz, 1 H), 7.54 (d, <i>J</i> = 8.78 Hz, 1 H), 7.68 (d, <i>J</i> = 7.28 Hz, 1 H), 7.90 (d, <i>J</i> = 7.28 Hz, 1 H), 8.26 (d, <i>J</i> = 2.26 Hz, 1 H), 8.33 (dd, <i>J</i> = 8.66, 2.13 Hz, 1 H). HRMS C<sub>24</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub>F<sub>3</sub>S (M + H)<sup>+</sup> calcd 494.1725, found 494.1728. LC/MS: <i>t</i><sub>R</sub> = 4.23 min, >95%, <i>m</i>/<i>z</i> 494.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-((2-Ethyl-3-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-3-yl)benzyl)(methyl)amino)-2-methylpropanoic Acid (<b>12b</b>)</h3><div class="NLM_p">To a solution of <b>10a</b> (650 mg, 1.55 mmol) in MeOH (10 mL) at 0 °C was added sodium borohydride (117 mg, 3.09 mmol). The reaction mixture was stirred at room temperature overnight. After removal of the solvent, the residue was dissolved in ethyl acetate (50 mL). The solution was washed with water and dried over anhydrous sodium sulfate. The dried solution was concentrated in vacuo to give the crude alcohol. The alcohol was dissolved in DCM (10 mL), and perbromomethane (615 mg, 1.86 mmol) was added at 0 °C, followed by a solution of triphenylphosphine (608 mg, 2.32 mmol) in DCM (10 mL). The reaction solution was stirred at room temperature for 1 h. The reaction mixture was concentrated in vacuo, and the residue was purified by chromatography on silica gel with petroleum/ethyl acetate (4:1) to give 400 mg (53%) of 3-(3-(bromomethyl)-2-ethylphenyl)-5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazole. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.29 (t, <i>J</i> = 7.40 Hz, 3 H), 1.44 (d, <i>J</i> = 6.02 Hz, 6 H), 3.14 (q, <i>J</i> = 7.40 Hz, 2 H), 4.67 (s, 2 H), 4.77 (dt, <i>J</i> = 12.11, 6.02 Hz, 1 H), 7.13 (d, <i>J</i> = 8.78 Hz, 1 H), 7.30–7.36 (m, 1 H), 7.50 (dd, <i>J</i> = 7.53, 1.25 Hz, 1 H), 7.90 (dd, <i>J</i> = 7.78, 1.25 Hz, 1 H), 8.14 (dd, <i>J</i> = 8.66, 2.13 Hz, 1 H), 8.24 (d, <i>J</i> = 2.01 Hz, 1 H). ESMS <i>m</i>/<i>z</i>: 485.0 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a solution of the above bromide (100 mg, 0.21 mmol) in DMF (5 mL) were added potassium carbonate (85 mg, 0.62 mmol) and 2-methyl-2-(methylamino)propanoic acid (29.0 mg, 0.25 mmol). The reaction mixture was heated at 60 °C overnight. After cooling, the reaction mixture was diluted with ethyl acetate (20 mL). The organic fraction was separated, washed with water, concentrated, and purified by MDAP to give 27 mg (21%) of <b>12b</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.16 (t, <i>J</i> = 7.28 Hz, 3 H), 1.34 (d, <i>J</i> = 6.02 Hz, 6 H), 1.51 (s, 6 H), 2.58 (s, 3 H), 2.99 (q, <i>J</i> = 7.28 Hz, 2 H), 4.96 (dt, <i>J</i> = 11.98, 6.02 Hz, 1 H), 5.42 (s, 2 H), 7.42 (t, <i>J</i> = 7.65 Hz, 1 H), 7.53 (d, <i>J</i> = 9.03 Hz, 1 H), 7.60 (d, <i>J</i> = 7.53 Hz, 1 H), 7.89 (d, <i>J</i> = 7.53 Hz, 1 H), 8.26 (s, 1 H), 8.29–8.37 (m, 1 H), 9.31 (br s, 1 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.4, 173.5, 170.7, 158.5, 158.1, 157.8, 142.2, 133.8, 133.7, 132.8, 131.6, 125.9, 121.7, 118.8, 118.5, 115.8, 71.7, 65.8, 60.9, 27.6, 22.2, 21.5, 21.1, 15.5. HRMS C<sub>26</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub>F<sub>3</sub>S (M + H)<sup>+</sup> calcd 522.2038, found 522.2048. LC/MS: <i>t</i><sub>R</sub> = 4.67 min, >95%, <i>m</i>/<i>z</i> 522.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1-(2-Ethyl-3-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-3-yl)benzyl)piperidine-4-carboxylic Acid (<b>12c</b>)</h3><div class="NLM_p last">To a solution of <b>10a</b> (80 mg, 0.19 mmol) in DCM (5 mL) and MeOH (5 mL) were added ethyl 4-piperidinecarboxylate (90 mg, 0.57 mmol) and acetic acid (0.022 mL, 0.38 mmol). The reaction solution was stirred at room temperature overnight. Sodium triacetoxyborohydride (81 mg, 0.381 mmol) was added, and stirring continued for another 2 h. After removal of the solvent, the residue was dissolved in ethyl acetate (50 mL). The organic fraction was separated, washed with water (2 × 10 mL), and concentrated to afford the ester. The ester was dissolved in isopropanol (5 mL) and water (5 mL), and NaOH (0.5 M in water) (1.90 mL, 0.95 mmol) was added. The reaction solution was heated at 90 °C for 2 h. After removal of the solvent, the residue was acidified to pH 3–4, extracted with ethyl acetate (2 × 20 mL). The combined organic phases were dried over sodium sulfate and concentrated, and the residue was purified by MDAP to give 44 mg (36%) <b>12c</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.08 (t, <i>J</i> = 7.40 Hz, 3 H), 1.34 (d, <i>J</i> = 6.02 Hz, 6 H), 1.77 (q, <i>J</i> = 12.30 Hz, 2 H), 2.08 (d, <i>J</i> = 13.30 Hz, 2 H), 3.04 (q, <i>J</i> = 6.78 Hz, 2 H), 3.12–3.26 (m, 2 H), 3.41–3.50 (m, 3 H), 4.38–4.54 (m, 2 H), 4.96 (dt, <i>J</i> = 12.05, 6.02 Hz, 1 H), 7.44–7.57 (m, 2 H), 7.71 (d, <i>J</i> = 7.53 Hz, 1 H), 7.91 (d, <i>J</i> = 7.53 Hz, 1 H), 8.26 (d, <i>J</i> = 2.01 Hz, 1 H), 8.33 (dd, <i>J</i> = 8.78, 2.01 Hz, 1 H), 9.24 (br s, 1 H), 12.58 (br s, 1 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.5, 174.6, 173.4, 158.5, 158.1, 143.7, 133.7, 133.3, 132.4, 126.4, 125.8, 124.5, 121.7, 118.9, 118.5, 115.8, 71.8, 56.1, 51.2, 38.0, 25.3, 22.7, 21.5, 16.0. HRMS C<sub>27</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub>F<sub>3</sub>S (M + H)<sup>+</sup> calcd 534.2038, found 534.2041. LC/MS: <i>t</i><sub>R</sub> = 4.26 min, >95%, <i>m</i>/<i>z</i> 534.3 (M + H)<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1-(2-Ethyl-3-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>12d</b>)</h3><div class="NLM_p last">Compound <b>12d</b> (44 mg, 37%) was prepared from <b>10a</b> (100 mg, 0.24 mmol) and methyl azetidine-3-carboxylate, HCl salt (72 mg, 0.48 mmol) in the same manner as described for <b>12c</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.12 (t, <i>J</i> = 7.40 Hz, 3 H), 1.34 (d, <i>J</i> = 6.02 Hz, 6 H), 2.93 (q, <i>J</i> = 7.40 Hz, 2 H), 3.18–3.28 (m, 3 H), 3.42 (t, <i>J</i> = 6.65 Hz, 2 H), 3.66 (s, 2 H), 4.95 (dt, <i>J</i> = 12.05, 6.02 Hz, 1 H), 7.30 (t, <i>J</i> = 7.65 Hz, 1 H), 7.45 (d, <i>J</i> = 6.53 Hz, 1 H), 7.52 (d, <i>J</i> = 8.78 Hz, 1 H), 7.67–7.73 (m, 1 H), 8.24 (d, <i>J</i> = 2.01 Hz, 1 H), 8.31 (dd, <i>J</i> = 8.78, 2.01 Hz, 1 H). LC/MS: <i>t</i><sub>R</sub> = 4.27 min, >95%, <i>m</i>/<i>z</i> 506.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-(3-(5-(3-Chloro-4-isopropoxyphenyl)-1,2,4-thiadiazol-3-yl)-2-ethylbenzyl)azetidine-3-carboxylic Acid (<b>12e</b>)</h3><div class="NLM_p last">Compound <b>12e</b> (40 mg, 33%) was prepared from <b>10b</b> (100 mg, 0.26 mmol) and methyl azetidine-3-carboxylate, HCl salt (59 mg, 0.39 mmol) in the same manner as described for <b>12c</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.11 (t, <i>J</i> = 7.28 Hz, 3 H), 1.34 (d, <i>J</i> = 6.02 Hz, 6 H), 2.93 (q, <i>J</i> = 7.28 Hz, 2 H), 3.19–3.28 (m, 3 H), 3.42 (t, <i>J</i> = 6.53 Hz, 2 H), 3.67 (s, 2 H), 4.85 (dt, <i>J</i> = 12.05, 6.02 Hz, 1 H), 7.26–7.32 (m, 1 H), 7.37 (d, <i>J</i> = 8.78 Hz, 1 H), 7.44 (d, <i>J</i> = 7.28 Hz, 1 H), 7.71 (d, <i>J</i> = 7.03 Hz, 1 H), 8.00 (dd, <i>J</i> = 8.66, 2.13 Hz, 1 H), 8.13 (d, <i>J</i> = 2.01 Hz, 1 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.2, 174.3, 174.1, 156.0, 141.7, 136.8, 132.6, 130.7, 129.7, 128.8, 127.9, 125.6, 123.1, 123.0, 115.5, 71.6, 60.4, 56.6, 33.6, 22.0, 21.7, 15.3. HRMS C<sub>24</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub>SCl (M + H)<sup>+</sup> calcd 472.1462, found 472.1462. LC/MS: <i>t</i><sub>R</sub> = 4.04 min, >95%, <i>m</i>/<i>z</i> 472.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-(3-(5-(3-Cyano-4-isobutylphenyl)-1,2,4-thiadiazol-3-yl)-2-ethylbenzyl)azetidine-3-carboxylic Acid (<b>12f</b>)</h3><div class="NLM_p last">Compound <b>12f</b> (51 mg, 33%) was prepared from <b>10c</b> (100 mg, 0.27 mmol) and methyl azetidine-3-carboxylate, HCl salt (42 mg, 0.28 mmol) in the same manner as described for <b>12c</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.94 (d, <i>J</i> = 6.78 Hz, 6 H), 1.10 (t, <i>J</i> = 7.40 Hz, 3 H), 1.99 (dt, <i>J</i> = 13.49, 6.78 Hz, 1 H), 2.78 (d, <i>J</i> = 7.28 Hz, 2 H), 3.00 (q, <i>J</i> = 7.03 Hz, 2 H), 3.66 (quin, <i>J</i> = 8.28 Hz, 1 H), 4.19–4.38 (m, 4 H), 4.58 (s, 2 H), 7.46 (t, <i>J</i> = 7.65 Hz, 1 H), 7.58 (d, <i>J</i> = 7.53 Hz, 1 H), 7.70 (d, <i>J</i> = 8.03 Hz, 1 H), 7.90 (d, <i>J</i> = 7.28 Hz, 1 H), 8.33 (dd, <i>J</i> = 8.16, 1.88 Hz, 1 H), 8.54 (d, <i>J</i> = 1.76 Hz, 1 H), 10.31 (br s, 1 H), 13.19 (br s, 1 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.1, 173.6, 158.1, 149.0, 142.7, 133.1, 132.0, 131.8, 131.5, 128.5, 126.4, 117.2, 113.2, 55.6, 54.4, 42.7, 32.3, 29.7, 22.4, 22.0, 15.7. HRMS C<sub>26</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub>S (M + H)<sup>+</sup> calcd 461.2011, found 461.2011. LC/MS: <i>t</i><sub>R</sub> = 4.11 min, >95%, <i>m</i>/<i>z</i> 461.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 3-(2-Ethyl-3-(2-methoxyvinyl)phenyl)-5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazole (<b>14a</b>)</h3><div class="NLM_p last">Compound <b>14a</b> (580 mg, 98%) was prepared from <b>8a</b> (487 mg, 1.33 mmol) and 2-(2-ethyl-3-(2-methoxyvinyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane <b>13</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (573 mg, 1.99 mmol) in the same manner as described for <b>10a</b> as a colorless oil except that the reaction time was 10 min. ESMS <i>m</i>/<i>z</i>: 449.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-(3-Chloro-4-isopropoxyphenyl)-3-(2-ethyl-3-(2-methoxyvinyl)phenyl)-1,2,4-thiadiazole (<b>14b</b>)</h3><div class="NLM_p last">Compound <b>14b</b> (313 mg, 65%) was prepared from <b>8b</b> (388 mg, 1.16 mmol) and <b>13</b> (335 mg, 1.16 mmol) in the same manner as described for <b>10a</b> as a colorless oil except that the reaction time was 10 min. ESMS <i>m</i>/<i>z</i>: 415.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 5-(3-(2-Ethyl-3-(2-methoxyvinyl)phenyl)-1,2,4-thiadiazol-5-yl)-2-isobutylbenzonitrile (<b>14c</b>)</h3><div class="NLM_p last">Compound <b>14c</b> (928 mg, 66%) was prepared from <b>8c</b> (1.13 g, 3.51 mmol) and <b>13</b> (1.11 g, 3.86 mmol) in the same manner as described for <b>10a</b> as an oil except that the reaction temperature was 110 °C. ESMS <i>m</i>/<i>z</i>: 404.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-(2-Ethyl-3-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-3-yl)phenyl)acetaldehyde (<b>15a</b>)</h3><div class="NLM_p last">To a solution of <b>14a</b> (140 mg, 0.31 mmol) in THF (10 mL) under nitrogen was added HCl (0.2 mL, 0.40 mmol). The reaction mixture was heated at 70 °C for 5 h. After the mixture was cooled, the solvent was concentrated under reduced pressure. The remaining trace hydrochloric acid was removed under high vacuum for 2 h to give 108 mg (80%) of <b>15a</b>, which was used for the following step without further purification. ESMS <i>m</i>/<i>z</i>: 435.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-(3-(5-(3-Chloro-4-isopropoxyphenyl)-1,2,4-thiadiazol-3-yl)-2-ethylphenyl)acetaldehyde (<b>15b</b>)</h3><div class="NLM_p last">Compound <b>15b</b> (300 mg, 99%) was prepared from <b>14b</b> (313 mg, 0.76 mmol) in the same manner as described for <b>15a</b>. ESMS <i>m</i>/<i>z</i>: 401.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 5-(3-(2-Ethyl-3-(2-oxoethyl)phenyl)-1,2,4-thiadiazol-5-yl)-2-isobutylbenzonitrile (<b>15c</b>)</h3><div class="NLM_p last">Compound <b>15c</b> (990 mg, 100%) was prepared from <b>14c</b> (1.03 g, 2.55 mmol) in the same manner as described for <b>15a</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ ppm 1.00 (d, <i>J</i> = 6.40 Hz, 6 H), 1.19 (t, <i>J</i> = 7.34 Hz, 3 H), 2.03–2.09 (m, 1 H), 2.81 (d, <i>J</i> = 7.15 Hz, 2 H), 2.97 (q, <i>J</i> = 7.34 Hz, 2 H), 3.86 (s, 2 H), 7.32–7.38 (m, 2 H), 7.45–7.49 (m, 1 H), 7.89 (d, <i>J</i> = 7.15 Hz, 1 H), 8.14 (d, <i>J</i> = 7.91 Hz, 1 H), 8.30 (s, 1 H), 9.79 (s, 1 H). ESMS <i>m</i>/<i>z</i>: 390.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-((2-Ethyl-3-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-3-yl)phenethyl)amino)acetic Acid (<b>17a</b>)</h3><div class="NLM_p last">Compound <b>17a</b> (5.6 mg, 11%) was prepared from <b>15a</b> (45 mg, 0.10 mmol) and glycinate (21 mg, 0.21 mmol) in the same manner as described for <b>12c</b>, giving a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.13 (t, <i>J</i> = 7.40 Hz, 3 H), 1.34 (d, <i>J</i> = 6.02 Hz, 6 H), 2.91 (q, <i>J</i> = 7.40 Hz, 2 H), 3.02 (s, 4 H), 3.22 (s, 2 H), 4.95 (dt, <i>J</i> = 12.05, 6.02 Hz, 1 H), 7.27–7.40 (m, 2 H), 7.52 (d, <i>J</i> = 9.03 Hz, 1 H), 7.68–7.72 (m, 1 H), 8.24 (d, <i>J</i> = 2.01 Hz, 1 H), 8.31 (dd, <i>J</i> = 8.78, 2.01 Hz, 1 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.2, 174.0, 158.4, 141.4, 136.8, 133.6, 132.8, 131.4, 129.5, 126.1, 125.9, 121.8, 118.5, 115.7, 71.7, 50.0, 47.8, 29.1, 22.2, 21.5, 15.7. HRMS C<sub>24</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub>F<sub>3</sub>S (M + H)<sup>+</sup> calcd 494.1725, found 494.1726. LC/MS: <i>t</i><sub>R</sub> = 3.37 min, >95%, <i>m</i>/<i>z</i> 494.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-((2-Ethyl-3-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-3-yl)phenethyl)(methyl)amino)acetic Acid (<b>17b</b>)</h3><div class="NLM_p last">Compound <b>17b</b> (9.2 mg, 17%) was prepared from <b>15a</b> (45 mg, 0.10 mmol) and ethyl 2-(methylamino)acetate (24.27 mg, 0.21 mmol) in the same manner as described for <b>12c</b>, giving a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.13 (t, <i>J</i> = 7.28 Hz, 3 H), 1.34 (d, <i>J</i> = 6.02 Hz, 6 H), 2.58 (s, 3 H), 2.88–2.97 (m, 4 H), 3.32 (s, 4 H), 4.95 (dt, <i>J</i> = 12.05, 6.02 Hz, 1 H), 7.30 (t, <i>J</i> = 7.65 Hz, 1 H), 7.38 (d, <i>J</i> = 6.78 Hz, 1 H), 7.53 (d, <i>J</i> = 8.78 Hz, 1 H), 7.67 (d, <i>J</i> = 7.78 Hz, 1 H), 8.25 (d, <i>J</i> = 1.76 Hz, 1 H), 8.32 (dd, <i>J</i> = 8.78, 2.01 Hz, 1 H). HRMS C<sub>25</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub>F<sub>3</sub>S (M + H)<sup>+</sup> calcd 508.1882, found 508.1888. LC/MS: <i>t</i><sub>R</sub> = 3.36 min, >95%, <i>m</i>/<i>z</i> 508.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(2-Ethyl-3-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-3-yl)phenethyl)piperidine-4-carboxylic Acid (<b>17c</b>)</h3><div class="NLM_p last">Compound <b>17c</b> (5 mg, 9%) was prepared from <b>15a</b> (45 mg, 0.10 mmol) and ethyl 4-piperidinecarboxylate (323 mg, 0.21 mmol) in the same manner as described for <b>12c</b>, giving a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.13 (t, <i>J</i> = 7.28 Hz, 3 H), 1.34 (d, <i>J</i> = 6.02 Hz, 6 H), 1.49–1.61 (m, 2 H), 1.80 (d, <i>J</i> = 13.80 Hz, 2 H), 2.01–2.10 (m, 2 H), 2.12–2.18 (m, 1 H), 2.81–2.94 (m, 8 H), 4.96 (dt, <i>J</i> = 12.11, 6.02 Hz, 1 H), 7.27 (t, <i>J</i> = 7.53 Hz, 1 H), 7.36 (d, <i>J</i> = 7.78 Hz, 1 H), 7.53 (d, <i>J</i> = 9.03 Hz, 1 H), 7.64 (dd, <i>J</i> = 7.65, 1.38 Hz, 1 H), 8.25 (d, <i>J</i> = 2.01 Hz, 1 H), 8.32 (dd, <i>J</i> = 8.66, 2.13 Hz, 1 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.6, 1774.7, 158.8, 141.5, 139.7, 134.1, 134.1, 133.0, 132.2, 129.3, 126.3, 122.3, 122.3, 116.2, 72.2, 60.5, 52.9, 30.1, 28.6, 22.8, 21.9, 16.1. HRMS C<sub>28</sub>H<sub>33</sub>N<sub>3</sub>O<sub>3</sub>F<sub>3</sub>S (M + H)<sup>+</sup> calcd 548.2195, found 548.2205. LC/MS: <i>t</i><sub>R</sub> = 3.48 min, >95%, <i>m</i>/<i>z</i> 548.3 (M + H)<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-(2-Ethyl-3-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-3-yl)phenethyl)azetidine-3-carboxylic Acid (<b>17d</b>)</h3><div class="NLM_p last">Compound <b>17d</b> (7 mg, 13%) was prepared from <b>15a</b> (45 mg, 0.10 mmol) and azetidinecarboxylate (24 mg, 0.21 mmol) in the same manner as described for <b>12c</b>, giving a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.12 (t, <i>J</i> = 7.28 Hz, 3 H), 1.34 (d, <i>J</i> = 6.02 Hz, 6 H), 2.58–2.64 (m, 2 H), 2.64–2.71 (m, 2 H), 2.89 (q, <i>J</i> = 7.28 Hz, 2 H), 3.12–3.21 (m, 5 H), 4.95 (dt, <i>J</i> = 12.05, 6.02 Hz, 1 H), 7.24–7.30 (m, 1 H), 7.33–7.38 (m, 1 H), 7.53 (d, <i>J</i> = 8.78 Hz, 1 H), 7.65 (dd, <i>J</i> = 7.53, 1.25 Hz, 1 H), 8.24 (d, <i>J</i> = 2.26 Hz, 1 H), 8.31 (dd, <i>J</i> = 8.66, 2.13 Hz, 1 H). HRMS C<sub>26</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub>F<sub>3</sub>S (M + H)<sup>+</sup> calcd 520.1882, found 520.1884. LC/MS: <i>t</i><sub>R</sub> = 3.43 min, >95%, <i>m</i>/<i>z</i> 520.2 (M + H)<sup>+</sup>.</div></div><div id="seca" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-(3-(5-(3-Chloro-4-isopropoxyphenyl)-1,2,4-thiadiazol-3-yl)-2-ethylphenethyl)piperidine-4-carboxylic Acid (<b>17e</b>)</h3><div class="NLM_p last">Compound <b>17e</b> (40 mg, 24%) was prepared from <b>15b</b> (100 mg, 0.25 mmol) and ethyl 4-piperidinecarboxylate (78 mg, 0.50 mmol) in the same manner as described for <b>12c</b>, giving a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.14 (t, <i>J</i> = 7.28 Hz, 3 H), 1.35 (d, <i>J</i> = 6.02 Hz, 6 H), 1.65–2.08 (m, 2 H), 2.10–2.18 (m, 2 H), 2.87–2.98 (m, 2 H), 2.98–3.17 (m, 4 H), 3.22–3.35 (m, 3 H), 3.70 (d, <i>J</i> = 11.80 Hz, 2 H), 4.86 (dt, <i>J</i> = 12.05, 6.02 Hz, 1 H), 7.29–7.46 (m, 3 H), 7.69–7.78 (m, 1 H), 8.02 (dd, <i>J</i> = 8.53, 2.26 Hz, 1 H), 8.14 (d, <i>J</i> = 2.26 Hz, 1 H), 9.56 (br s, 1 H), 12.66 (br s, 1 H). HRMS C<sub>27</sub>H<sub>33</sub>N<sub>3</sub>O<sub>3</sub>SCl (M + H)<sup>+</sup> calcd 514.1931, found 514.1935. LC/MS: <i>t</i><sub>R</sub> = 3.39 min, >95%, <i>m</i>/<i>z</i> 514.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-(3-(5-(3-Chloro-4-isopropoxyphenyl)-1,2,4-thiadiazol-3-yl)-2-ethylphenethyl)azetidine-3-carboxylic Acid (<b>17f</b>)</h3><div class="NLM_p last">Compound <b>17f</b> (32 mg, 21%) was prepared from <b>15b</b> (100 mg, 0.25 mmol) and methyl 3-azetidinecarboxylate (57 mg, 0.50 mmol) in the same manner as described for <b>12c</b>, giving a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.12 (t, <i>J</i> = 7.40 Hz, 3 H), 1.35 (d, <i>J</i> = 6.02 Hz, 6 H), 2.86–2.96 (m, 4 H), 3.38–3.44 (m, 2 H), 3.60–3.66 (m, 1 H), 4.18–4.39 (m, 4 H), 4.86 (dt, <i>J</i> = 12.05, 6.02 Hz, 1 H), 7.31–7.46 (m, 3 H), 7.71–7.76 (m, 1 H), 8.02 (dd, <i>J</i> = 8.66, 2.13 Hz, 1 H), 8.14 (d, <i>J</i> = 2.26 Hz, 1 H), 10.17 (br s, 1 H), 13.21 (br s, 1 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.3, 173.9, 156.0, 141.5, 135.6, 132.9, 131.5, 129.8, 128.7, 128.0, 126.1, 123.1, 122.9, 115.5, 71.6, 55.4, 55.1, 32.4, 27.0, 22.3, 21.6, 15.6. HRMS C<sub>25</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub>SCl (M + H)<sup>+</sup> calcd 486.1618, found 486.1620. LC/MS: <i>t</i><sub>R</sub> = 3.32 min, >95%, <i>m</i>/<i>z</i> 486.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-(3-(5-(3-Cyano-4-isobutylphenyl)-1,2,4-thiadiazol-3-yl)-2-ethylphenethyl)piperidine-4-carboxylic Acid (<b>17g</b>)</h3><div class="NLM_p last">Compound <b>17g</b> (86 mg, 49%) was prepared from <b>15c</b> (110 mg, 0.28 mmol) and ethyl 4-piperidinecarboxylate (58 mg, 0.37 mmol) in the same manner as described for <b>12c</b>, giving a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.94 (d, <i>J</i> = 6.53 Hz, 6 H), 1.15 (t, <i>J</i> = 7.28 Hz, 3 H), 1.69–2.03 (m, 3 H), 2.13 (d, <i>J</i> = 13.05 Hz, 2 H), 2.78 (d, <i>J</i> = 7.28 Hz, 2 H), 2.94 (q, <i>J</i> = 7.28 Hz, 2 H), 3.00–3.16 (m, 4 H), 3.25–3.32 (m, 2 H), 3.53 (d, <i>J</i> = 12.55 Hz, 1 H), 3.70 (d, <i>J</i> = 11.80 Hz, 2 H), 7.33–7.40 (m, 1 H), 7.40–7.46 (m, 1 H), 7.70 (d, <i>J</i> = 8.28 Hz, 1 H), 7.73–7.79 (m, 1 H), 8.33 (dd, <i>J</i> = 8.16, 1.88 Hz, 1 H), 8.53 (d, <i>J</i> = 1.76 Hz, 1 H), 9.44 (br s, 1 H), 12.62 (br s, 1 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.0, 174.6, 174.1, 149.0, 141.5, 135.7, 132.8, 131.8, 131.5, 130.2, 128.5, 126.2, 117.2, 113.2, 51.1, 42.7, 38.0, 29.8, 26.6, 25.5, 22.4, 22.0, 15.8. HRMS C<sub>29</sub>H<sub>35</sub>N<sub>4</sub>O<sub>2</sub>S (M + H)<sup>+</sup> calcd 503.2481, found 503.2491. LC/MS: <i>t</i><sub>R</sub> = 4.15 min, >95%, <i>m</i>/<i>z</i> 503.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-(3-(5-(3-Cyano-4-isobutylphenyl)-1,2,4-thiadiazol-3-yl)-2-ethylphenethyl)azetidine-3-carboxylic Acid (<b>17h</b>)</h3><div class="NLM_p last">Compound <b>17h</b> (24 mg, 14%) was prepared from <b>15c</b> (110 mg, 0.28 mmol) and methyl azetidine-3-carboxylate, HCl salt (45 mg, 0.30 mmol) in the same manner as described for <b>12c</b>, giving a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.94 (d, <i>J</i> = 6.78 Hz, 6 H), 1.13 (t, <i>J</i> = 7.28 Hz, 3 H), 1.99 (dt, <i>J</i> = 13.49, 6.78 Hz, 1 H), 2.78 (d, <i>J</i> = 7.28 Hz, 2 H), 2.87–2.97 (m, 4 H), 3.38–3.44 (m, 2 H), 3.57–3.68 (m, 1 H), 4.18–4.34 (m, 4 H), 7.33–7.39 (m, 1 H), 7.42–7.47 (m, 1 H), 7.70 (d, <i>J</i> = 8.03 Hz, 1 H), 7.74–7.79 (m, 1 H), 8.33 (dd, <i>J</i> = 8.16, 1.88 Hz, 1 H), 8.53 (d, <i>J</i> = 1.76 Hz, 1 H), 10.06 (br s, 1 H), 13.14 (br s, 1 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 184.9, 174.0, 158.3, 157.9, 148.9, 141.5, 135.6, 132.7, 131.7, 131.6, 131.5, 129.9, 128.5, 126.1, 117.2, 113.1, 55.3, 54.9, 42.7, 32.3, 29.7, 26.9, 22.3, 21.9, 15.6. HRMS C<sub>27</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub>S (M + H)<sup>+</sup> calcd 475.2168, found 475.2176. LC/MS: <i>t</i><sub>R</sub> = 4.10 min, >95%, <i>m</i>/<i>z</i> 475.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-(3-(2-Ethyl-3-(2-(3-hydroxyazetidin-1-yl)ethyl)phenyl)-1,2,4-thiadiazol-5-yl)-2-isobutylbenzonitrile (<b>17i</b>)</h3><div class="NLM_p last">To a solution of 3-azetidinol (38 mg, 0.51 mmol) and <b>15c</b> (100 mg, 0.26 mmol) in DCM (10 mL), which was prestirred at room temperature for 20 min, was added sodium triacetoxyborohydride (108 mg, 0.51 mmol). The reaction mixture was stirred at room temperature for 2 h. Afterward, the reaction was quenched with water. The reaction mixture was concentrated in vacuo, and the residue was purified by MDAP to give 20 mg (17%) of <b>17i</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.93 (d, <i>J</i> = 6.53 Hz, 6 H), 1.11 (t, <i>J</i> = 7.40 Hz, 3 H), 1.98 (dt, <i>J</i> = 13.36, 6.53 Hz, 1 H), 2.57–2.64 (m, 2 H), 2.64–2.79 (m, 6 H), 2.90 (q, <i>J</i> = 7.40 Hz, 2 H), 3.52–3.58 (m, 2 H), 4.11–4.20 (m, 1 H), 5.30 (d, <i>J</i> = 5.52 Hz, 1 H), 7.26 (t, <i>J</i> = 7.65 Hz, 1 H), 7.35 (d, <i>J</i> = 7.03 Hz, 1 H), 7.67 (dd, <i>J</i> = 7.40, 3.89 Hz, 2 H), 8.31 (dd, <i>J</i> = 8.28, 1.51 Hz, 1 H), 8.50 (s, 1 H). HRMS C<sub>26</sub>H<sub>31</sub>N<sub>4</sub>OS (M + H)<sup>+</sup> calcd 447.2219, found 447.2217. LC/MS: <i>t</i><sub>R</sub> = 3.29 min, >95%, <i>m</i>/<i>z</i> 447.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-(3-(2-Ethyl-3-(2-(piperidin-1-yl)ethyl)phenyl)-1,2,4-thiadiazol-5-yl)-2-isobutylbenzonitrile (<b>17j</b>)</h3><div class="NLM_p last">Compound <b>17j</b> (48 mg, 32%) was prepared from <b>15c</b> (100 mg, 0.26 mmol) and piperidine (109 mg, 1.28 mmol) in the same manner as described for <b>17i</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.94 (d, <i>J</i> = 6.53 Hz, 6 H), 1.15 (t, <i>J</i> = 7.40 Hz, 3 H), 1.34–1.48 (m, 1 H), 1.59–1.79 (m, 3 H), 1.88 (d, <i>J</i> = 14.31 Hz, 2 H), 1.99 (dt, <i>J</i> = 13.36, 6.53 Hz, 1 H), 2.78 (d, <i>J</i> = 7.28 Hz, 2 H), 2.90–3.00 (m, 4 H), 3.07–3.16 (m, 2 H), 3.27 (dt, <i>J</i> = 12.05, 4.77 Hz, 2 H), 3.61 (d, <i>J</i> = 11.54 Hz, 2 H), 7.33–7.40 (m, 1 H), 7.40–7.45 (m, 1 H), 7.70 (d, <i>J</i> = 8.03 Hz, 1 H), 7.76 (dd, <i>J</i> = 7.53, 1.25 Hz, 1 H), 8.33 (dd, <i>J</i> = 8.16, 1.88 Hz, 1 H), 8.53 (d, <i>J</i> = 1.76 Hz, 1 H), 9.39 (br s, 1 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 184.9, 174.1, 158.2, 157.9, 149.0, 141.5, 135.9, 132.8, 129.9, 128.5, 126.2, 118.6, 117.2, 115.6, 113.1, 56.4, 52.1, 42.7, 29.7, 26.5, 22.7, 22.3, 21.9, 21.4, 15.7. HRMS C<sub>28</sub>H<sub>35</sub>N<sub>4</sub>S (M + H)<sup>+</sup> calcd 459.2582, found 459.2592. LC/MS: <i>t</i><sub>R</sub> = 3.55 min, >95%, <i>m</i>/<i>z</i> 459.3 (M + H)<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> CNS Penetration Study (BBR) in Male Mice after ip Administration</h3><div class="NLM_p last">Six male C57BL/6 mice received an ip injection of the test compound at 2 mg/kg. The dose was prepared on the day of administration in a suspension (DMSO/1% methylcellulose = 1:99 as the vehicle) at a concentration of 0.2 mg/mL (dose volume of 10 mL/kg). At 1, 2, and 4 h after ip administration, blood samples (50 μL per animal) from two of the animals were collected. An amount of 30 μL of blood was then diluted with 90 μL of water. Immediately after blood collection, whole brains of the two animals were quickly removed and rinsed with cold H<sub>2</sub>O and surface vasculature was ruptured and blotted with dry tissue. Brain tissue was homogenized with 3× PBS (w/v). Blood and brain samples were analyzed by LC/MS/MS. The measured concentrations were corrected for dilution factor, and then the brain-to-blood ratio (BBR) was determined based on the ratio of brain concentration and blood concentration at each time point (1, 2, and 4 h):<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/jm-2011-016107_m001.gif" alt="" /></img></span></div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Lymphopenia Study in Male Mice after po Administration</h3><div class="NLM_p last">Animals (<i>n</i> = 3/group) were treated once with various doses of the compounds (and vehicle) via oral gavage. At predetermined time points (including immediately prior to compound administration), 50 μL of peripheral blood was obtained and the number of lymphocytes therein was determined by flow cytometry and expressed as relative percentages of the baseline value at time 0. For repeat dose studies, animals were dosed daily for a week and lymphocyte counts were determined either just prior to or 4 h after dosing every day except on days 5 and 6, which were the weekend.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> EAE Induction and Treatment</h3><div class="NLM_p last">For induction and treatment of EAE, male C57BL/6 mice (6–8 weeks old) were purchased from the Shanghai Laboratory Animal Center and were maintained under pathogen-free conditions. Mice were immunized subcutaneously with a synthetic peptide (300 μg) of myelin oligodendrocyte glycoprotein (MOG) corresponding to residues 35–55 (GL Biochem, Shanghai, China). Immunization was performed by mixing MOG peptide in complete Freund adjuvant containing 5 mg/mL heat-killed H37Ra, strain of <i>Mycobacterium tuberculosis</i> (Difco Laboratories, Detroit, MI). Pertussis toxin (200 ng, List Biological Laboratories, Campbell, CA) in PBS was administered iv on the day of immunization and 48 h later. For treatment of EAE, compounds or vehicle (DMSO in PBS) was administered at 1 mg/kg po daily from day 10 after immunization onward. Mice were examined daily and scored for disease severity using the following standard scale: 0, no clinical signs; 1, limp tail; 2, paraparesis (weakness, incomplete paralysis of one or two hind limbs); 3, paraplegia (complete paralysis of two hind limbs); 4, paraplegia with forelimb weakness or paralysis; 5, moribund or death. The animal use protocol was approved by Institutional Animal Care and Use Committee of GSK R&D China.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44"><a href="/doi/suppl/10.1021/jm2016107">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthesis procedures and spectral data for compounds <b>3</b>, <b>4a</b>–<b>u</b>, and <b>5a</b>–<b>l</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2016107/suppl_file/jm2016107_si_001.pdf">jm2016107_si_001.pdf (517.94 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm2016107" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xichen Lin</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#124a7b717a777c3c203c5e7b7c527561793c717d7f"><span class="__cf_email__" data-cfemail="cf97a6aca7aaa1e1fde183a6a18fa8bca4e1aca0a2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng Ren</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guanghui Deng</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hailong Wang</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linbo Luan</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qinghua Meng</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiongfeng Xu</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heng Xu</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xuesong Xu</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haibo Zhang</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Baowei Zhao</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chengyong Li</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Taylor B. Guo</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiansong Yang</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Zhang</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yonggang Zhao</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiantao Jia</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongtao Lu</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia-Ning Xiang</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. Elliott</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, R&D China, No. 3 Building, 898
Halei Road, Zhangjiang Hi-Tech Park, Pudong,
Shanghai 201203, PRC</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d918e3935-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67436" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67436" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Drs. Eric Y. Yang, Hong Lu, and Zongping Zhang for their helpful comments and discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i46" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i46"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> Abbreviations Used</h2><tr><td class="NLM_term">AI</td><td class="NLM_def"><p class="first last">aromatic index</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under curve</p></td></tr><tr><td class="NLM_term">BBR</td><td class="NLM_def"><p class="first last">brain to blood ratio</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">EAE</td><td class="NLM_def"><p class="first last">experimental autoimmune encephalomyelitis</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term"><i>F</i><sub>u</sub></td><td class="NLM_def"><p class="first last">free unbound fraction</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">HP-β-CD</td><td class="NLM_def"><p class="first last">2-hydroxypropyl-β-cyclodextrin</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">MC</td><td class="NLM_def"><p class="first last">methylcellulose</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamic</p></td></tr><tr><td class="NLM_term">PdCl<sub>2</sub>(dppf)</td><td class="NLM_def"><p class="first last">1,1′-bis(diphenylphosphino)ferrocenepalladium(II) dichloride</p></td></tr><tr><td class="NLM_term">Pd(PPh<sub>3</sub>)<sub>4</sub></td><td class="NLM_def"><p class="first last">tetrakis(triphenylphosphine)palladium(0)</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">oral</p></td></tr><tr><td class="NLM_term">RRMS</td><td class="NLM_def"><p class="first last">relapsing-remitting multiple sclerosis</p></td></tr><tr><td class="NLM_term">S1P<sub>1</sub></td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate receptor 1</p></td></tr><tr><td class="NLM_term">S1P<sub>3</sub></td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate receptor 3</p></td></tr><tr><td class="NLM_term">S1P<sub>4</sub></td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate receptor 4</p></td></tr><tr><td class="NLM_term">S1P<sub>5</sub></td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate receptor 5</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Compston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coles, A.</span><span> </span><span class="NLM_article-title">Multiple Sclerosis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1221</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1016%2FS0140-6736%2802%2908220-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=11955556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A280%3ADC%252BD383hvVegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2002&pages=1221-1231&author=A.+Compstonauthor=A.+Coles&title=Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple sclerosis</span></div><div class="casAuthors">Compston Alastair; Coles Alasdair</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">9313</span>),
    <span class="NLM_cas:pages">1221-31</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">Multiple sclerosis is the prototype inflammatory autoimmune disorder of the central nervous system and, with a lifetime risk of one in 400, potentially the most common cause of neurological disability in young adults.  As with all complex traits, the disorder results from an interplay between as yet unidentified environmental factors and susceptibility genes.  Together, these factors trigger a cascade of events, involving engagement of the immune system, acute inflammatory injury of axons and glia, recovery of function and structural repair, post-inflammatory gliosis, and neurodegeneration.  The sequential involvement of these processes underlies the clinical course characterised by episodes with recovery, episodes leaving persistent deficits, and secondary progression.  The aim of treatment is to reduce the frequency, and limit the lasting effects, of relapses, relieve symptoms, prevent disability arising from disease progression, and promote tissue repair.  Despite limited success in each of these categories, everyone touched by multiple sclerosis looks for a better dividend from applying an improved understanding of the pathogenesis to clinical management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRIu2mS4c49KqcneEtCi92fW6udTcc2ebU9CS_LpzTarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383hvVegsA%253D%253D&md5=dafa765f3049d15a63843d54643d144e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2802%2908220-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252802%252908220-X%26sid%3Dliteratum%253Aachs%26aulast%3DCompston%26aufirst%3DA.%26aulast%3DColes%26aufirst%3DA.%26atitle%3DMultiple%2520Sclerosis%26jtitle%3DLancet%26date%3D2002%26volume%3D359%26spage%3D1221%26epage%3D1231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Sorbera, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulsat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, E.</span><span> </span><span class="NLM_article-title">Therapeutic Targets for Multiple Sclerosis</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1358%2Fdof.2009.034.05.1364290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSqtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=405-417&author=L.+A.+Sorberaauthor=C.+Dulsatauthor=E.+Rosa&title=Therapeutic+Targets+for+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targets for multiple sclerosis</span></div><div class="casAuthors">Sorbera, L. A.; Dulsat, C.; Rosa, E.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">405-417</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is an inflammatory disorder of the brain and spinal cord in which focal lymphocytic infiltration leads to myelin and axonal damage.  Although first described in the 14th century, MS was untreatable until the 1990s, when interferon beta (IFN-β) reached the market for the first time.  Four different IFNs and glatiramer acetate all obtained regulatory approval in the 1990s, radically influencing the treatment of MS.  Since then, novel strategies have been developed for the treatment of MS, including targeting of leukocyte differentiation mols., costimulatory mols., antiadhesion mols. and chemotaxis; immunomodulatory agents, autologous stem cell transplantation, anti-infectious therapies and strategies for neuroprotection, neurorepair and remyelination have also emerged.  However, there is still no cure for MS and existing treatments serve only to slow disease progression and mitigate symptoms.  The search for effective treatments for MS continues, with researchers focusing on the identification of novel targets for therapeutic intervention.  This article presents those drug targets that are currently under active investigation for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoubXHI5LQzTLVg90H21EOLACvtfcHk0ljzvqJV3mT0yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSqtbnF&md5=3efae49411bad286dd81bbe50565debf</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1358%2Fdof.2009.034.05.1364290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2009.034.05.1364290%26sid%3Dliteratum%253Aachs%26aulast%3DSorbera%26aufirst%3DL.%2BA.%26aulast%3DDulsat%26aufirst%3DC.%26aulast%3DRosa%26aufirst%3DE.%26atitle%3DTherapeutic%2520Targets%2520for%2520Multiple%2520Sclerosis%26jtitle%3DDrugs%2520Future%26date%3D2009%26volume%3D34%26spage%3D405%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): Discovery and Development of an Oral Drug to Treat Multiple Sclerosis</span> <span class="citation_source-journal">Nat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+Discovery+and+Development+of+an+Oral+Drug+to+Treat+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0ljzvqJV3mT0yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520Discovery%2520and%2520Development%2520of%2520an%2520Oral%2520Drug%2520to%2520Treat%2520Multiple%2520Sclerosis%26jtitle%3DNat.%2520Rev.%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lublin, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutter, G.</span><span> </span><span class="NLM_article-title">Effect of Relapses on Development of Residual Deficit in Multiple Sclerosis</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1528</span><span class="NLM_x">–</span> <span class="NLM_lpage">1532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=1528-1532&author=F.+D.+Lublinauthor=M.+Baierauthor=G.+Cutter&title=Effect+of+Relapses+on+Development+of+Residual+Deficit+in+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLublin%26aufirst%3DF.%2BD.%26aulast%3DBaier%26aufirst%3DM.%26aulast%3DCutter%26aufirst%3DG.%26atitle%3DEffect%2520of%2520Relapses%2520on%2520Development%2520of%2520Residual%2520Deficit%2520in%2520Multiple%2520Sclerosis%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D1528%26epage%3D1532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">FTY720: Sphingosine 1-Phosphate Receptor-1 in the Control of Lymphocyte Egress and Endothelial Barrier Function</span> <span class="citation_source-journal">Am. J. Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1111%2Fj.1600-6143.2004.00476.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=15196057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFGksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=1019-1025&author=V.+Brinkmannauthor=J.+G.+Cysterauthor=T.+Hla&title=FTY720%3A+Sphingosine+1-Phosphate+Receptor-1+in+the+Control+of+Lymphocyte+Egress+and+Endothelial+Barrier+Function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function</span></div><div class="casAuthors">Brinkmann, Volker; Cyster, Jason G.; Hla, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Transplantation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1019-1025</span>CODEN:
                <span class="NLM_cas:coden">AJTMBR</span>;
        ISSN:<span class="NLM_cas:issn">1600-6135</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The novel immunomodulator FTY720 is effective in exptl. models of transplantation and autoimmunity, and is currently undergoing Phase III clin. trials for prevention of kidney graft rejection.  In contrast to conventional immunosuppressants, FTY720 does not impair T- and B-cell activation, proliferation and effector function, but interferes with cell traffic between lymphoid organs and blood.  The mol. basis for the mode of action of the drug has only recently been established.  FTY720, after phosphorylation, acts as a high-affinity agonist at the G protein-coupled sphingosine 1-phosphate receptor-1 (S1P1) on thymocytes and lymphocytes, thereby inducing aberrant internalization of the receptor.  This renders the cells unresponsive to the serum lipid sphingosine 1-phosphate (S1P), depriving them from an obligatory signal to egress from lymphoid organs.  As a consequence, lymphocytes are unable to recirculate to peripheral inflammatory tissues and graft sites but remain functional in the lymphoid compartment.  In addn. to the effects on lymphocyte recirculation, the drug acts on endothelial cells and preserves vascular integrity by enhancing adherens junction assembly and endothelial barrier function.  The available data establish S1P1 as a key target for FTY720, and further point to therapeutically relevant effects of the drug on lymphocytes and vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpucC2_LbDXlrVg90H21EOLACvtfcHk0ljzvqJV3mT0yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFGksLw%253D&md5=c18b89e72deeb928d68dabbca0f7ad37</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-6143.2004.00476.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-6143.2004.00476.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DFTY720%253A%2520Sphingosine%25201-Phosphate%2520Receptor-1%2520in%2520the%2520Control%2520of%2520Lymphocyte%2520Egress%2520and%2520Endothelial%2520Barrier%2520Function%26jtitle%3DAm.%2520J.%2520Transplant.%26date%3D2004%26volume%3D4%26spage%3D1019%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Miron, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarjour, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliven, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720) Enhances Remyelination following Demyelination of Organotypic Cerebellar Slices</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">2682</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.2353%2Fajpath.2010.091234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=20413685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2010&pages=2682-2694&author=V.+E.+Mironauthor=S.+K.+Ludwinauthor=P.+J.+Darlingtonauthor=A.+A.+Jarjourauthor=B.+Solivenauthor=T.+E.+Kennedyauthor=J.+P.+Antel&title=Fingolimod+%28FTY720%29+Enhances+Remyelination+following+Demyelination+of+Organotypic+Cerebellar+Slices"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices</span></div><div class="casAuthors">Miron, Veronique E.; Ludwin, Samuel K.; Darlington, Peter J.; Jarjour, Andrew A.; Soliven, Betty; Kennedy, Timothy E.; Antel, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2682-2694</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Remyelination, which occurs subsequent to demyelination, contributes to functional recovery and is mediated by oligodendrocyte progenitor cells (OPCs) that have differentiated into myelinating cells.  Therapeutics that impact remyelination in the CNS could be crit. determinants of long-term functional outcome in multiple sclerosis (MS).  Fingolimod is a S1P receptor modulator in MS clin. trials due to systemic anti-inflammatory properties, yet may impact cells within the CNS by crossing the blood-brain barrier.  Previous studies using isolated dissocd. cultures indicate that neural cells express S1P receptors and respond to receptor engagement.  Our objective was to assess the effects of fingolimod on myelinrelated processes within a multicellular environment that maintains physiol. cell-cell interactions, using organotypic cerebellar slice cultures.  Fingolimod treatment had no impact on myelin under basal conditions.  Fingolimod treatment subsequent to lysolecithin-induced demyelination enhanced remyelination and process extension by OPCs and mature oligodendrocytes, while increasing microglia nos. and immunoreactivity for the astrocytic marker glial fibrillary acidic protein.  The no. of phagocytosing microglia was not increased by fingolimod.  Using S1P receptor specific agonists and antagonists, we detd. that fingolimod-induced effects on remyelination and astrogliosis were mediated primarily through S1P3 and S1P5, whereas enhanced microgliosis was mediated through S1P1 and S1P5.  Taken together, these data demonstrate that fingolimod modulates multiple neuroglial cell responses, resulting in enhanced remyelination in organotypic slice cultures that maintain the complex cellular interactions of the mammalian brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradvge9335h7Vg90H21EOLACvtfcHk0ljQnqRvwZgLfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D&md5=6e7efa55ed7482a64dad66c6ec384de8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.091234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.091234%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DDarlington%26aufirst%3DP.%2BJ.%26aulast%3DJarjour%26aufirst%3DA.%2BA.%26aulast%3DSoliven%26aufirst%3DB.%26aulast%3DKennedy%26aufirst%3DT.%2BE.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26atitle%3DFingolimod%2520%2528FTY720%2529%2520Enhances%2520Remyelination%2520following%2520Demyelination%2520of%2520Organotypic%2520Cerebellar%2520Slices%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D176%26spage%3D2682%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Choi, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Astrocytic Sphingosine 1-Phosphate (S1P) Receptor Subtype 1 Signalling Influences Levels of S1P and Cytokines during Experimental Autoimmune Encephalomyelitis and Fingolimod (FTY720) Intervention</span> <span class="citation_source-journal">Mult. Scler.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">S58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=S58&author=J.+W.+Choiauthor=D.+Herrauthor=G.+Kennedyauthor=J.+Chun&title=Astrocytic+Sphingosine+1-Phosphate+%28S1P%29+Receptor+Subtype+1+Signalling+Influences+Levels+of+S1P+and+Cytokines+during+Experimental+Autoimmune+Encephalomyelitis+and+Fingolimod+%28FTY720%29+Intervention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DHerr%26aufirst%3DD.%26aulast%3DKennedy%26aufirst%3DG.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DAstrocytic%2520Sphingosine%25201-Phosphate%2520%2528S1P%2529%2520Receptor%2520Subtype%25201%2520Signalling%2520Influences%2520Levels%2520of%2520S1P%2520and%2520Cytokines%2520during%2520Experimental%2520Autoimmune%2520Encephalomyelitis%2520and%2520Fingolimod%2520%2528FTY720%2529%2520Intervention%26jtitle%3DMult.%2520Scler.%26date%3D2009%26volume%3D15%26spage%3DS58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of Lymphocyte Trafficking by Sphingosine-1 Phosphate Receptor Agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+Lymphocyte+Trafficking+by+Sphingosine-1+Phosphate+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520Lymphocyte%2520Trafficking%2520by%2520Sphingosine-1%2520Phosphate%2520Receptor%2520Agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The Immune Modulator FTY720 Targets Sphingosine-1-Phosphate Receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+Immune+Modulator+FTY720+Targets+Sphingosine-1-Phosphate+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520Immune%2520Modulator%2520FTY720%2520Targets%2520Sphingosine-1-Phosphate%2520Receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Verzijl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span> </span><span class="NLM_article-title">Sphingosine-1-Phosphate Receptors: Zooming in on Ligand-Induced Intracellular Trafficking and Its Functional Implications</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=99-104&author=D.+Verzijlauthor=S.+L.+M.+Petersauthor=A.+E.+Alewijnse&title=Sphingosine-1-Phosphate+Receptors%3A+Zooming+in+on+Ligand-Induced+Intracellular+Trafficking+and+Its+Functional+Implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerzijl%26aufirst%3DD.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26atitle%3DSphingosine-1-Phosphate%2520Receptors%253A%2520Zooming%2520in%2520on%2520Ligand-Induced%2520Intracellular%2520Trafficking%2520and%2520Its%2520Functional%2520Implications%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D29%26spage%3D99%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte Egress from Thymus and Peripheral Lymphoid Organs Is Dependent on S1P Receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+Egress+from+Thymus+and+Peripheral+Lymphoid+Organs+Is+Dependent+on+S1P+Receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520Egress%2520from%2520Thymus%2520and%2520Peripheral%2520Lymphoid%2520Organs%2520Is%2520Dependent%2520on%2520S1P%2520Receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Expression of the Sphingosine-1-Phosphate, S1P<sub>1</sub>, on T-Cells Controls Thymic Emigration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15396</span><span class="NLM_x">–</span> <span class="NLM_lpage">15401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15396-15401&author=M.+L.+Allendeauthor=J.+L.+Dreierauthor=S.+Mandalaauthor=R.+L.+Proia&title=Expression+of+the+Sphingosine-1-Phosphate%2C+S1P1%2C+on+T-Cells+Controls+Thymic+Emigration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DDreier%26aufirst%3DJ.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DExpression%2520of%2520the%2520Sphingosine-1-Phosphate%252C%2520S1P1%252C%2520on%2520T-Cells%2520Controls%2520Thymic%2520Emigration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15396%26epage%3D15401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Mizugishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Essential Role for Sphingosine Kinases in Neural and Vascular Development</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">11113</span><span class="NLM_x">–</span> <span class="NLM_lpage">11121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1128%2FMCB.25.24.11113-11121.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=16314531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlektr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=11113-11121&author=K.+Mizugishiauthor=T.+Yamashitaauthor=A.+Oliveraauthor=G.+F.+Millerauthor=S.+Spiegelauthor=R.+L.+Proia&title=Essential+Role+for+Sphingosine+Kinases+in+Neural+and+Vascular+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Essential role for sphingosine kinases in neural and vascular development</span></div><div class="casAuthors">Mizugishi, Kiyomi; Yamashita, Tadashi; Olivera, Ana; Miller, Georgina F.; Spiegel, Sarah; Proia, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11113-11121</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate (S1P), an important sphingolipid metabolite, regulates diverse cellular processes, including cell survival, growth, and differentiation.  Here we show that S1P signaling is crit. for neural and vascular development.  Sphingosine kinase-null mice exhibited a deficiency of S1P which severely disturbed neurogenesis, including neural tube closure, and angiogenesis and caused embryonic lethality.  A dramatic increase in apoptosis and a decrease in mitosis were seen in the developing nervous system.  S1P1 receptor-null mice also showed severe defects in neurogenesis, indicating that the mechanism by which S1P promotes neurogenesis is, in part, signaling from the S1P1 receptor.  Thus, S1P joins a growing list of signaling mols., such as vascular endothelial growth factor, which regulate the functionally intertwined pathways of angiogenesis and neurogenesis.  Our findings also suggest that exploitation of this potent neuronal survival pathway could lead to the development of novel therapeutic approaches for neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1FtMYvASa3bVg90H21EOLACvtfcHk0lipdYifCYKdqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlektr3N&md5=3757d4b2b18d6f9e4526df92c7a595d4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.24.11113-11121.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.24.11113-11121.2005%26sid%3Dliteratum%253Aachs%26aulast%3DMizugishi%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DOlivera%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DG.%2BF.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DEssential%2520Role%2520for%2520Sphingosine%2520Kinases%2520in%2520Neural%2520and%2520Vascular%2520Development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D11113%26epage%3D11121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kovarik, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riviere, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldwater, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R. L.</span><span> </span><span class="NLM_article-title">The Effect on Heart Rate of Combining Single-Dose Fingolimod with Steady-State Atenolol or Diltiazem in Healthy Subjects</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=457-463&author=J.+M.+Kovarikauthor=M.+Luauthor=G.+Riviereauthor=I.+Barbetauthor=S.+Matonauthor=D.+R.+Goldwaterauthor=R.+L.+Schmouder&title=The+Effect+on+Heart+Rate+of+Combining+Single-Dose+Fingolimod+with+Steady-State+Atenolol+or+Diltiazem+in+Healthy+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKovarik%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DRiviere%26aufirst%3DG.%26aulast%3DBarbet%26aufirst%3DI.%26aulast%3DMaton%26aufirst%3DS.%26aulast%3DGoldwater%26aufirst%3DD.%2BR.%26aulast%3DSchmouder%26aufirst%3DR.%2BL.%26atitle%3DThe%2520Effect%2520on%2520Heart%2520Rate%2520of%2520Combining%2520Single-Dose%2520Fingolimod%2520with%2520Steady-State%2520Atenolol%2520or%2520Diltiazem%2520in%2520Healthy%2520Subjects%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D64%26spage%3D457%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimarco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastien, M.-C.</span><span> </span><span class="NLM_article-title">FTY720: Placebo-Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1177%2F0091270006289853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=16855074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1Kjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=895-904&author=R.+Schmouderauthor=D.+Serraauthor=Y.+Wangauthor=J.+M.+Kovarikauthor=J.+Dimarcoauthor=T.+L.+Huntauthor=M.-C.+Bastien&title=FTY720%3A+Placebo-Controlled+Study+of+the+Effect+on+Cardiac+Rate+and+Rhythm+in+Healthy+Subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720: placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects</span></div><div class="casAuthors">Schmouder, Robert; Serra, Denise; Wang, Yibin; Kovarik, John M.; DiMarco, John; Hunt, Thomas L.; Bastien, Marie-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">895-904</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The purpose of this double-blind, placebo-controlled study was to measure the effects of FTY720, a novel immunomodulator, on heart rate and rhythm in healthy volunteers.  Subjects (n = 66) were randomized to FTY720 1.25 mg or 5 mg or placebo administered once daily for 7 days.  Continuous telemetry revealed an acute, dose-dependent decrease in mean heart rate (10-bpm decrease vs. placebo) following the first dose of FTY720, with a nadir generally 4 h postdose.  Although a persistent FTY720-related decrease in heart rate was measured from day 2 to day 7, addnl. doses of FTY720 after day 2 resulted in no further incremental decreases.  Mean PR interval increased by approx. 8 to 10 ms in FTY720-treated subjects on day 1.  FTY720 did not increase the QRS or QT interval.  These results confirm that the first dose of FTY720 has a mild to moderate neg. chronotropic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB7QxNA7zcX7Vg90H21EOLACvtfcHk0lipdYifCYKdqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1Kjtrg%253D&md5=4b32061d569b5dc4e7b5030e52feef0e</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1177%2F0091270006289853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270006289853%26sid%3Dliteratum%253Aachs%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DSerra%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKovarik%26aufirst%3DJ.%2BM.%26aulast%3DDimarco%26aufirst%3DJ.%26aulast%3DHunt%26aufirst%3DT.%2BL.%26aulast%3DBastien%26aufirst%3DM.-C.%26atitle%3DFTY720%253A%2520Placebo-Controlled%2520Study%2520of%2520the%2520Effect%2520on%2520Cardiac%2520Rate%2520and%2520Rhythm%2520in%2520Healthy%2520Subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D895%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune Cell Regulation and Cardiovascular Effects of Sphingosine-1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tiamauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+Cell+Regulation+and+Cardiovascular+Effects+of+Sphingosine-1-Phosphate+Receptor+Agonists+in+Rodents+Are+Mediated+via+Distinct+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0lipdYifCYKdqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTiam%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520Cell%2520Regulation%2520and%2520Cardiovascular%2520Effects%2520of%2520Sphingosine-1-Phosphate%2520Receptor%2520Agonists%2520in%2520Rodents%2520Are%2520Mediated%2520via%2520Distinct%2520Receptor%2520Subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, Respectively, Regulate Lymphocyte Recirculation and Heart Rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.-Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-Phosphate+%28S1P%29+Receptor+Subtypes+S1P1+and+S1P3%2C+Respectively%2C+Regulate+Lymphocyte+Recirculation+and+Heart+Rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-Phosphate%2520%2528S1P%2529%2520Receptor%2520Subtypes%2520S1P1%2520and%2520S1P3%252C%2520Respectively%252C%2520Regulate%2520Lymphocyte%2520Recirculation%2520and%2520Heart%2520Rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enosawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeyoshi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span> </span><span class="NLM_article-title">KRP-203, a Novel Synthetic Immunosuppressant, Prolongs Graft Survival and Attenuates Chronic Rejection in Rat Skin and Heart Allografts</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=222-229&author=H.+Shimizuauthor=M.+Takahashiauthor=T.+Kanekoauthor=T.+Murakamiauthor=Y.+Hakamataauthor=S.+Kudouauthor=T.+Kishiauthor=K.+Fukuchiauthor=S.+Iwanamiauthor=K.+Kuriyamaauthor=T.+Yasueauthor=S.+Enosawaauthor=K.+Matsumotoauthor=I.+Takeyoshiauthor=Y.+Morishitaauthor=E.+Kobayashi&title=KRP-203%2C+a+Novel+Synthetic+Immunosuppressant%2C+Prolongs+Graft+Survival+and+Attenuates+Chronic+Rejection+in+Rat+Skin+and+Heart+Allografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DHakamata%26aufirst%3DY.%26aulast%3DKudou%26aufirst%3DS.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DFukuchi%26aufirst%3DK.%26aulast%3DIwanami%26aufirst%3DS.%26aulast%3DKuriyama%26aufirst%3DK.%26aulast%3DYasue%26aufirst%3DT.%26aulast%3DEnosawa%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTakeyoshi%26aufirst%3DI.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DE.%26atitle%3DKRP-203%252C%2520a%2520Novel%2520Synthetic%2520Immunosuppressant%252C%2520Prolongs%2520Graft%2520Survival%2520and%2520Attenuates%2520Chronic%2520Rejection%2520in%2520Rat%2520Skin%2520and%2520Heart%2520Allografts%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D222%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, F. L. S.</span><span> </span><span class="NLM_article-title">Quantitative Determination of BAF312, a S1P-R Modulator, in Human Urine by LC–MS/MS: Prevention and Recovery of Lost Analyte Due to Container Surface Adsorption</span> <span class="citation_source-journal">J. Chromatogr. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">878</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1016%2Fj.jchromb.2009.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=20097141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1yhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=878&publication_year=2010&pages=583-589&author=W.+Liauthor=S.+Luoauthor=H.+T.+Smithauthor=F.+L.+S.+Tse&title=Quantitative+Determination+of+BAF312%2C+a+S1P-R+Modulator%2C+in+Human+Urine+by+LC%E2%80%93MS%2FMS%3A+Prevention+and+Recovery+of+Lost+Analyte+Due+to+Container+Surface+Adsorption"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative determination of BAF312, a S1P-R modulator, in human urine by LC-MS/MS: Prevention and recovery of lost analyte due to container surface adsorption</span></div><div class="casAuthors">Li, Wenkui; Luo, Suyi; Smith, Harold T.; Tse, Francis L. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">878</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">583-589</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Analyte loss due to non-specific binding, esp. container surface adsorption, is not uncommon in the quant. anal. of urine samples.  In developing a sensitive LC-MS/MS method for the detn. of a drug candidate, BAF312, in human urine, a simple procedure was outlined for identification, confirmation and prevention of analyte non-specific binding to a container surface and to recover the non-specific loss' of an analyte, if no transfer has occurred to the original urine samples.  Non-specific binding or container surface adsorption can be quickly identified by using freshly spiked urine calibration stds. and pre-pooled QC samples during a LC-MS/MS feasibility run.  The resulting low recovery of an analyte in urine samples can be prevented through the use of additives, such as the non-ionic surfactant Tween-80, CHAPS and others, to the container prior to urine sample collection.  If the urine samples have not been transferred from the bulk container, the non-specific binding' of an analyte to the container surface can be reversed by the addn. of a specified amt. of CHAPS, Tween-80 or bovine serum albumin, followed by appropriate mixing.  Among the above agents, Tween-80 is the most cost-effective.  β-Cyclodextrin may be suitable in stabilizing the analyte of interest in urine via pre-treating the matrix with the agent.  However, post-addn. of β-cyclodextrin to untreated urine samples does not recover the lost' analyte due to non-specific binding or container surface adsorption.  In the case of BAF312, a dynamic range of 0.0200-20.0 ng/mL in human urine was validated with an overall accuracy and precision for QC sample results ranging from -3.2 to 5.1% (bias) and 3.9 to 10.2% (CV), resp.  Pre- and post-addn. of 0.5% (vol./vol.) Tween-80 to the container provided excellent overall analyte recovery and minimal MS signal suppression when a liq.-liq. extn. in combination with an isocratic LC sepn. was employed.  The compd. was stable in 0.5% Tween-80 treated human urine QC samples for at least 24 h at room temp., after three freeze/thaw cycles with storage at ≤-60 °C and for at least 3 mo when stored at ≤-60 °C.  The current work could serve as a simple example in trouble shooting non-specific binding or container surface adsorption in quant. anal. of urine samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3wQU6DKpY97Vg90H21EOLACvtfcHk0lhVaidhvtyw0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1yhsrw%253D&md5=40c0794ce5595b9a129b14645e6a0be9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2009.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2009.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DTse%26aufirst%3DF.%2BL.%2BS.%26atitle%3DQuantitative%2520Determination%2520of%2520BAF312%252C%2520a%2520S1P-R%2520Modulator%252C%2520in%2520Human%2520Urine%2520by%2520LC%25E2%2580%2593MS%252FMS%253A%2520Prevention%2520and%2520Recovery%2520of%2520Lost%2520Analyte%2520Due%2520to%2520Container%2520Surface%2520Adsorption%26jtitle%3DJ.%2520Chromatogr.%2520B%26date%3D2010%26volume%3D878%26spage%3D583%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menuhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P<sub>1</sub> Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menuhartauthor=C.+Mullerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-Imino-thiazolidin-4-one+Derivatives+as+Potent%2C+Orally+Active+S1P1+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenuhart%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-Imino-thiazolidin-4-one%2520Derivatives%2520as%2520Potent%252C%2520Orally%2520Active%2520S1P1%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Buzard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Recent Progress in the Development of Selective S1P<sub>1</sub> Receptor Agonists for the Treatment of Inflammatory and Autoimmune Disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1517%2F13543776.18.10.1141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1141-1159&author=D.+Buzardauthor=J.+Thatteauthor=M.+Lernerauthor=J.+Edwardsauthor=R.+M.+Jones&title=Recent+Progress+in+the+Development+of+Selective+S1P1+Receptor+Agonists+for+the+Treatment+of+Inflammatory+and+Autoimmune+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders</span></div><div class="casAuthors">Buzard, Daniel J.; Thatte, Jayant; Lerner, Michael; Edwards, Jeffrey; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1141-1159</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The sphingosine-1-phosphate receptor 1 (S1P1) belongs to the endothelial differentiation gene family of G-protein-coupled receptors involved in embryonic development, cellular differentiation and survival, adherence and tight junction assembly, and leukocyte trafficking.  In vivo S1P1 is required for egress of thymocytes into the blood and of naive lymphocytes from secondary lymphoid organs back into the lymph.  Downregulation of S1P1 disrupts lymphocyte migration, tissue homing and recirculation.  To explore the immunomodulatory potential of S1P1, pharma is developing S1P1-selective agonists for treating autoimmune and inflammatory disorders.  FTY720 (fingolimod, Novartis AG), a nonselective S1P1 agonist that induces sustained lymphopenia, is a promising pseudo-lipid aminodiol prodrug that has been shown in preclin. and early clin. trials to be effective in suppressing various autoimmune conditions and to aid in acute organ transplant, and is currently in pivotal Phase III clin. trials for relapsing-remitting multiple sclerosis.  In this review article, we outline recent advances made in the discovery and patenting of new small-mol. S1P1 selective agonists and summarize a rapidly growing body of intellectual property.  Fingolimod-like S1P1 agonists with a novel mechanism of action have emerged as promising immunosuppressants.  S1P1 agonists induce T-cell sequestration in lymph nodes and Peyer's patches, diminishing their ability to reach distant sites and cause pathol.  Preclin. studies have already provided preliminary evidence that low-dose treatment with fingolimod in conjunction with subtherapeutic doses of cyclosporin A and tacrolimus enable potent immunosuppression in the absence of immediately serious side effects.  Future efforts will det. whether S1P1 agonists do indeed synergize with existing DMAs to create new mutidrug paradigms with superior efficacy and safety for the treatment of autoimmune diseases and the prevention of organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoio59l2iXb2rVg90H21EOLACvtfcHk0lhyLqUv31V75w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK&md5=fe911f7d9d3fb961c7df50663bffc245</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.10.1141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.10.1141%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DLerner%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520Selective%2520S1P1%2520Receptor%2520Agonists%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520and%2520Autoimmune%2520Disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1141%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budhu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. M.</span><span> </span><span class="NLM_article-title">2-Aryl(pyrrolidin-4-yl)acetic Acids Are Potent Agonists of Sphingosine-1-Phosphate (S1P) Receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3564</span><span class="NLM_x">–</span> <span class="NLM_lpage">3568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3564-3568&author=L.+Yanauthor=R.+Budhuauthor=P.+Huoauthor=C.+L.+Lynchauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=S.+M.+Mandala&title=2-Aryl%28pyrrolidin-4-yl%29acetic+Acids+Are+Potent+Agonists+of+Sphingosine-1-Phosphate+%28S1P%29+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DBudhu%26aufirst%3DR.%26aulast%3DHuo%26aufirst%3DP.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3D2-Aryl%2528pyrrolidin-4-yl%2529acetic%2520Acids%2520Are%2520Potent%2520Agonists%2520of%2520Sphingosine-1-Phosphate%2520%2528S1P%2529%2520Receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3564%26epage%3D3568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. M.</span><span> </span><span class="NLM_article-title">Discovery of 3-Arylpropionic Acids as Potent Agonists of Sphingosine-1-Phosphate Receptor-1 (S1P<sub>1</sub>) with High Selectivity against All Other Known S1P Receptor Subtypes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3679</span><span class="NLM_x">–</span> <span class="NLM_lpage">3683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3679-3683&author=L.+Yanauthor=P.+Huoauthor=G.+Dohertyauthor=L.+Tothauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=E.+Quackenbushauthor=A.+Wickhamauthor=S.+M.+Mandala&title=Discovery+of+3-Arylpropionic+Acids+as+Potent+Agonists+of+Sphingosine-1-Phosphate+Receptor-1+%28S1P1%29+with+High+Selectivity+against+All+Other+Known+S1P+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DHuo%26aufirst%3DP.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DToth%26aufirst%3DL.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DWickham%26aufirst%3DA.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%25203-Arylpropionic%2520Acids%2520as%2520Potent%2520Agonists%2520of%2520Sphingosine-1-Phosphate%2520Receptor-1%2520%2528S1P1%2529%2520with%2520High%2520Selectivity%2520against%2520All%2520Other%2520Known%2520S1P%2520Receptor%2520Subtypes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3679%26epage%3D3683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vachal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Highly Selective and Potent Agonists of Sphingosine-1-Phosphate 1 (S1P<sub>1</sub>) Receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3684</span><span class="NLM_x">–</span> <span class="NLM_lpage">3687</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3684-3687&author=P.+Vachalauthor=L.+M.+Tothauthor=J.+J.+Haleauthor=L.+Yanauthor=S.+G.+Millsauthor=G.+L.+Chrebetauthor=C.+A.+Keohaneauthor=R.+Hajduauthor=J.+A.+Milliganauthor=M.+J.+Rosenbachauthor=S.+Mandala&title=Highly+Selective+and+Potent+Agonists+of+Sphingosine-1-Phosphate+1+%28S1P1%29+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DToth%26aufirst%3DL.%2BM.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChrebet%26aufirst%3DG.%2BL.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DHighly%2520Selective%2520and%2520Potent%2520Agonists%2520of%2520Sphingosine-1-Phosphate%25201%2520%2528S1P1%2529%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3684%26epage%3D3687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. M.</span><span> </span><span class="NLM_article-title">SAR Studies of 3-Arylpropionic Acids as Potent and Selective Agonists of Sphingosine-1-Phosphate Receptor-1 (S1P<sub>1</sub>) with Enhanced Pharmacokinetic Properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">831</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=828-831&author=L.+Yanauthor=P.+Huoauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=S.+M.+Mandala&title=SAR+Studies+of+3-Arylpropionic+Acids+as+Potent+and+Selective+Agonists+of+Sphingosine-1-Phosphate+Receptor-1+%28S1P1%29+with+Enhanced+Pharmacokinetic+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DHuo%26aufirst%3DP.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3DSAR%2520Studies%2520of%25203-Arylpropionic%2520Acids%2520as%2520Potent%2520and%2520Selective%2520Agonists%2520of%2520Sphingosine-1-Phosphate%2520Receptor-1%2520%2528S1P1%2529%2520with%2520Enhanced%2520Pharmacokinetic%2520Properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D828%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Deng, G.; Lin, X.; Meng, Q.; Ren, F.; Xiang, J.; Xu, H.; Zhao, B.; Zhang, H.</span><span> </span><span class="NLM_article-title">Preparation of 5-Membered Heteroaryl Derivatives as Sphingosine 1-Phosphate Receptor Agonists</span>. WO2010148649(A1),<span class="NLM_x"> </span><span class="NLM_year">2010</span>. Mouse experimental autoimmune encephalomyelitis (EAE) data are unpublished results from this laboratory.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=G.+Deng&author=X.+Lin&author=Q.+Meng&author=F.+Ren&author=J.+Xiang&author=H.+Xu&author=B.+Zhao&author=H.+Zhang&title=Preparation+of+5-Membered+Heteroaryl+Derivatives+as+Sphingosine+1-Phosphate+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DG.%26atitle%3DPreparation%2520of%25205-Membered%2520Heteroaryl%2520Derivatives%2520as%2520Sphingosine%25201-Phosphate%2520Receptor%2520Agonists%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">Unpublished results from this laboratory. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental procedure for the mouse CNS penetration study.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lan, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weliky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, E. C.</span><span> </span><span class="NLM_article-title">Metabolic Studies with <i>trans</i>-5-Amino-3-[2-5-nitro-2-furyl]vinyl]-1,2,4-[5-<sup>14</sup>C]oxadiazole (SQ18,506): 1. Reductive Cleavage of the 1,2,4-Oxadiazole Ring</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1973&pages=97-102&author=S.+J.+Lanauthor=I.+Welikyauthor=E.+C.+Schreiber&title=Metabolic+Studies+with+trans-5-Amino-3-%5B2-5-nitro-2-furyl%5Dvinyl%5D-1%2C2%2C4-%5B5-14C%5Doxadiazole+%28SQ18%2C506%29%3A+1.+Reductive+Cleavage+of+the+1%2C2%2C4-Oxadiazole+Ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DS.%2BJ.%26aulast%3DWeliky%26aufirst%3DI.%26aulast%3DSchreiber%26aufirst%3DE.%2BC.%26atitle%3DMetabolic%2520Studies%2520with%2520trans-5-Amino-3-%255B2-5-nitro-2-furyl%255Dvinyl%255D-1%252C2%252C4-%255B5-14C%255Doxadiazole%2520%2528SQ18%252C506%2529%253A%25201.%2520Reductive%2520Cleavage%2520of%2520the%25201%252C2%252C4-Oxadiazole%2520Ring%26jtitle%3DXenobiotica%26date%3D1973%26volume%3D3%26spage%3D97%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span> </span><span class="NLM_article-title">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+Reactions+of+Five-Membered+Aromatic+Heterocyclic+Rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0ljAieFAXpQ8yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520Reactions%2520of%2520Five-Membered%2520Aromatic%2520Heterocyclic%2520Rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sendzik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, H. C.</span><span> </span><span class="NLM_article-title">Environmentally Friendly and Efficient: Iron-Mediated Reduction of 3-Methyl-5-aryl-1,2,4-oxadiazoles to Benzamidines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">8697</span><span class="NLM_x">–</span> <span class="NLM_lpage">8700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=8697-8700&author=M.+Sendzikauthor=H.+C.+Hui&title=Environmentally+Friendly+and+Efficient%3A+Iron-Mediated+Reduction+of+3-Methyl-5-aryl-1%2C2%2C4-oxadiazoles+to+Benzamidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DH.%2BC.%26atitle%3DEnvironmentally%2520Friendly%2520and%2520Efficient%253A%2520Iron-Mediated%2520Reduction%2520of%25203-Methyl-5-aryl-1%252C2%252C4-oxadiazoles%2520to%2520Benzamidines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D8697%26epage%3D8700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bird, C. W.</span><span> </span><span class="NLM_article-title">A New Aromaticity Index and Its Application to Five-membered Ring Heterocycles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1409</span><span class="NLM_x">–</span> <span class="NLM_lpage">1414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1016%2FS0040-4020%2801%2996543-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADyaL2MXlsVWjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1985&pages=1409-1414&author=C.+W.+Bird&title=A+New+Aromaticity+Index+and+Its+Application+to+Five-membered+Ring+Heterocycles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">A new aromaticity index and its application to five-membered ring heterocycles</span></div><div class="casAuthors">Bird, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1409-14</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">A new index of arom. character has been devised based upon a statistical evaluation of the deviations in peripheral bond orders.  The latter can be derived readily from exptl. detd. bond lengths.  The utility of this index is exemplified by its application to five-membered ring heterocycles and their mesoionic derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2uSjjYeOflLVg90H21EOLACvtfcHk0ljAieFAXpQ8yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlsVWjtLc%253D&md5=36fda67f5c5cfe606bc49eb69f86e16f</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2996543-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252996543-3%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DC.%2BW.%26atitle%3DA%2520New%2520Aromaticity%2520Index%2520and%2520Its%2520Application%2520to%2520Five-membered%2520Ring%2520Heterocycles%26jtitle%3DTetrahedron%26date%3D1985%26volume%3D41%26spage%3D1409%26epage%3D1414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bird, C. W.</span><span> </span><span class="NLM_article-title">The Application of a New Aromaticity Index to Six-Membered Ring Heterocycles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1986&pages=89-92&author=C.+W.+Bird&title=The+Application+of+a+New+Aromaticity+Index+to+Six-Membered+Ring+Heterocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DC.%2BW.%26atitle%3DThe%2520Application%2520of%2520a%2520New%2520Aromaticity%2520Index%2520to%2520Six-Membered%2520Ring%2520Heterocycles%26jtitle%3DTetrahedron%26date%3D1986%26volume%3D42%26spage%3D89%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">S1P<sub>1</sub> FRET assay was conducted according to the manufacturer’s protocol (catalog no. K1520, Invitrogen, Carlsbad, CA).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">S1P<sub>3</sub> FRET assay was conducted according to the manufacturer’s protocol (catalog no. K1713, Invitrogen, Carlsbad, CA).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and Computational Approaches To Estimate Solubility and Permeability in Drug Discovery and Development Settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+Computational+Approaches+To+Estimate+Solubility+and+Permeability+in+Drug+Discovery+and+Development+Settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lihtB63Rb6WUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520Computational%2520Approaches%2520To%2520Estimate%2520Solubility%2520and%2520Permeability%2520in%2520Drug%2520Discovery%2520and%2520Development%2520Settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Fessey, R. E.; Austin, R. P.; Barton, P.; Davis, A. M.; Wenlock, M. C.</span><span> </span><span class="NLM_article-title">The Role of Plasma Protein Binding in Drug Discovery</span>. In  <span class="citation_source-book">Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies</span>, LogP2004: 3rd Lipophilicity Symposium, Zurich, Switzerland, Feb 29–Mar 4, 2004; <span class="NLM_contrib-group">Testa, B.</span>, <span class="NLM_etal">et al.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1002%2F9783906390468.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=119-141&author=R.+E.+Fessey&author=R.+P.+Austin&author=P.+Barton&author=A.+M.+Davis&author=M.+C.+Wenlockauthor=B.+Testa&title=Pharmacokinetic+Profiling+in+Drug+Research%3A+Biological%2C+Physicochemical%2C+and+Computational+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2F9783906390468.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783906390468.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DFessey%26aufirst%3DR.%2BE.%26atitle%3DThe%2520Role%2520of%2520Plasma%2520Protein%2520Binding%2520in%2520Drug%2520Discovery%26btitle%3DPharmacokinetic%2520Profiling%2520in%2520Drug%2520Research%253A%2520Biological%252C%2520Physicochemical%252C%2520and%2520Computational%2520Strategies%26aulast%3DTesta%26aufirst%3DB.%26pub%3DWiley-VCH%26date%3D2006%26spage%3D119%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><div class="note"><p class="first last">For EAE protocol, refer to the following: </p></div><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. Z.</span><span> </span><span class="NLM_article-title">Crucial Role of Interleukin-7 in T Helper Type 17 Survival and Expansion in Autoimmune Disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1038%2Fnm.2077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=20062065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjsVaqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=191-197&author=X.+Liuauthor=L.+Leungauthor=C.+Wangauthor=Z.+Tanauthor=J.+Wangauthor=T.+B.+Guoauthor=L.+Fangauthor=Y.+Zhaoauthor=B.+Wanauthor=X.+Qinauthor=L.+Luauthor=R.+Liauthor=H.+Panauthor=M.+Songauthor=A.+Liuauthor=J.+Hongauthor=H.+Luauthor=J.+Z.+Zhang&title=Crucial+Role+of+Interleukin-7+in+T+Helper+Type+17+Survival+and+Expansion+in+Autoimmune+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease</span></div><div class="casAuthors">Liu, Xuebin; Leung, Stewart; Wang, Chunxia; Tan, Zhu; Wang, Ji; Guo, Taylor B.; Fang, Lei; Zhao, Yonggang; Wan, Bing; Qin, Xia; Lu, Limin; Li, Runsheng; Pan, Heng; Song, Mingjuan; Liu, Ailian; Hong, Jian; Lu, Hongtao; Zhang, Jingwu Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-197</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interleukin-7 receptor (IL-7R) is genetically assocd. with susceptibility to multiple sclerosis.  Here the authors describe that IL-7 is essential for survival and expansion of pathogenic T helper type 17 (TH17) cells in exptl. autoimmune encephalomyelitis (EAE).  IL-7 directly expanded effector TH17 cells in EAE and human TH17 cells from subjects with multiple sclerosis, whereas it was not required for TH17 differentiation.  IL-7R antagonism rendered differentiated TH17 cells susceptible to apoptosis through the inhibition of Janus kinase-signal transducer and activator of transcription-5 (JAK-STAT5) pathway and altered expression of the prosurvival protein Bcl-2 and the proapoptotic protein Bax, leading to decreased severity of EAE.  In contrast, TH1 and regulatory T (Treg) cells were less susceptible to or not affected by IL-7R antagonism in vivo.  The selectivity was attributable to minimal expression of IL-7Rα in Treg cells and correlated with a high level of Socs1 (encoding suppressor of cytokine signaling-1) expression in TH1 cells.  The study reveals a unique, previously undescribed role of IL-7-IL-7R in TH17 cell survival and expansion and has implications in the treatment of autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhIC8NGvTt8rVg90H21EOLACvtfcHk0lihtB63Rb6WUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjsVaqsA%253D%253D&md5=aea9279dec76bfa82e08ea6e7c6c408b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnm.2077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2077%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DT.%2BB.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%2BZ.%26atitle%3DCrucial%2520Role%2520of%2520Interleukin-7%2520in%2520T%2520Helper%2520Type%252017%2520Survival%2520and%2520Expansion%2520in%2520Autoimmune%2520Disease%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D191%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lin, X.; Ren, F.; Zhang, H.</span><span> </span><span class="NLM_article-title">Pyrimidine Derivatives for Use as Sphingosine 1-Phosphate 1 (S1P<sub>1</sub>) Receptor Agonists</span>. WO2011113309(A1),<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=X.+Lin&author=F.+Ren&author=H.+Zhang&title=Pyrimidine+Derivatives+for+Use+as+Sphingosine+1-Phosphate+1+%28S1P1%29+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26atitle%3DPyrimidine%2520Derivatives%2520for%2520Use%2520as%2520Sphingosine%25201-Phosphate%25201%2520%2528S1P1%2529%2520Receptor%2520Agonists%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c','cit11d'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16c','cit16d'],'ref17':['cit17'],'ref18':[],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20a','cit20b'],'ref21':[],'ref22':[],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John L.  Gilmore</span>, <span class="hlFld-ContribAuthor ">James E.  Sheppeck, II</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Lauren  Haque</span>, <span class="hlFld-ContribAuthor ">Parag  Mukhopadhyay</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Tebben</span>, <span class="hlFld-ContribAuthor ">Michael A.  Galella</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Virna  Borowski</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">Tracy  Taylor</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Bethanne  Warrack</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Julia P.  Li</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Anthony  Marino</span>, <span class="hlFld-ContribAuthor ">Praveen  Balimane</span>, <span class="hlFld-ContribAuthor ">Luisa  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, and <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Structure–Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6248-6264. <a href="https://doi.org/10.1021/acs.jmedchem.6b00373" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00373%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252B%252528SAR%252529%252Bof%252Ba%252BSeries%252Bof%252BEthanolamine-Based%252BDirect-Acting%252BAgonists%252Bof%252BSphingosine-1-phosphate%252B%252528S1P1%252529%26aulast%3DGilmore%26aufirst%3DJohn%2BL.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29032016%26date%3D01072016%26date%3D14072016%26date%3D16062016%26volume%3D59%26issue%3D13%26spage%3D6248%26epage%3D6264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Stefan  Abele</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Roberto  Bravo</span>, <span class="hlFld-ContribAuthor ">Daniel  Bur</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">Julien  Grimont</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Cyrille  Lescop</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Michael  Scherz</span>, <span class="hlFld-ContribAuthor ">Gunther  Schmidt</span>, <span class="hlFld-ContribAuthor ">Jürgen  Seifert</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>, <span class="hlFld-ContribAuthor ">Jörg  Velker</span>, and <span class="hlFld-ContribAuthor ">Thomas  Weller</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (1)
                                     , 110-130. <a href="https://doi.org/10.1021/jm4014696" title="DOI URL">https://doi.org/10.1021/jm4014696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4014696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4014696%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P1%252BReceptor%252BAgonists%252B%2525E2%252588%252592%252BPart%252B3%25253A%252BFrom%252BThiophenes%252Bto%252BPyridines%26aulast%3DBolli%26aufirst%3DMartin%2BH.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D23092013%26date%3D24122013%26date%3D09012014%26volume%3D57%26issue%3D1%26spage%3D110%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shifeng  Pan</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Wenqi  Gao</span>, <span class="hlFld-ContribAuthor ">Yuan  Mi</span>, <span class="hlFld-ContribAuthor ">Yi  Fan</span>, <span class="hlFld-ContribAuthor ">Xing  Wang</span>, <span class="hlFld-ContribAuthor ">Tove  Tuntland</span>, <span class="hlFld-ContribAuthor ">Jianwei  Che</span>, <span class="hlFld-ContribAuthor ">Sophie  Lefebvre</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Alan  Chu</span>, <span class="hlFld-ContribAuthor ">Klaus  Hinterding</span>, <span class="hlFld-ContribAuthor ">Anne  Gardin</span>, <span class="hlFld-ContribAuthor ">Peter  End</span>, <span class="hlFld-ContribAuthor ">Peter  Heining</span>, <span class="hlFld-ContribAuthor ">Christian  Bruns</span>, <span class="hlFld-ContribAuthor ">Nigel G.  Cooke</span>, and <span class="hlFld-ContribAuthor ">Barbara  Nuesslein-Hildesheim</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (3)
                                     , 333-337. <a href="https://doi.org/10.1021/ml300396r" title="DOI URL">https://doi.org/10.1021/ml300396r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml300396r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml300396r%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BBAF312%252B%252528Siponimod%252529%25252C%252Ba%252BPotent%252Band%252BSelective%252BS1P%252BReceptor%252BModulator%26aulast%3DPan%26aufirst%3DShifeng%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D15112012%26date%3D04012013%26date%3D08012013%26date%3D14032013%26date%3D04012013%26volume%3D4%26issue%3D3%26spage%3D333%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minghua  Chen</span>, <span class="hlFld-ContribAuthor ">Sheng  Lin</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Chenggen  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Wang</span>, <span class="hlFld-ContribAuthor ">Yanan  Wang</span>, <span class="hlFld-ContribAuthor ">Bingya  Jiang</span>, <span class="hlFld-ContribAuthor ">Sujuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yuhuan  Li</span>, <span class="hlFld-ContribAuthor ">Jiandong  Jiang</span>, and <span class="hlFld-ContribAuthor ">Jiangong  Shi</span>  . </span><span class="cited-content_cbyCitation_article-title">Enantiomers of an Indole Alkaloid Containing Unusual Dihydrothiopyran and 1,2,4-Thiadiazole Rings from the Root of Isatis indigotica. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2012,</strong> <em>14 </em>
                                    (22)
                                     , 5668-5671. <a href="https://doi.org/10.1021/ol302660t" title="DOI URL">https://doi.org/10.1021/ol302660t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol302660t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol302660t%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEnantiomers%252Bof%252Ban%252BIndole%252BAlkaloid%252BContaining%252BUnusual%252BDihydrothiopyran%252Band%252B1%25252C2%25252C4-Thiadiazole%252BRings%252Bfrom%252Bthe%252BRoot%252Bof%252BIsatis%252Bindigotica%26aulast%3DChen%26aufirst%3DMinghua%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D26092012%26date%3D06112012%26date%3D16112012%26volume%3D14%26issue%3D22%26spage%3D5668%26epage%3D5671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yafei  Liu</span>, <span class="hlFld-ContribAuthor ">Yurong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Liang  Hu</span>, <span class="hlFld-ContribAuthor ">Shiqing  Han</span>. </span><span class="cited-content_cbyCitation_article-title">A copper-catalyzed approach for the synthesis of asymmetrical disubstituted 1,2,4-thiadiazoles via elemental sulfur-mediated decarboxylative redox cyclization. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>65 </em>, 152744. <a href="https://doi.org/10.1016/j.tetlet.2020.152744" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.152744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.152744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.152744%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bcopper-catalyzed%252Bapproach%252Bfor%252Bthe%252Bsynthesis%252Bof%252Basymmetrical%252Bdisubstituted%252B1%25252C2%25252C4-thiadiazoles%252Bvia%252Belemental%252Bsulfur-mediated%252Bdecarboxylative%252Bredox%252Bcyclization%26aulast%3DLiu%26aufirst%3DYafei%26date%3D2021%26volume%3D65%26spage%3D152744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Walker</span>. </span><span class="cited-content_cbyCitation_article-title">Improvement in aqueous solubility achieved via small molecular changes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (23)
                                     , 5100-5108. <a href="https://doi.org/10.1016/j.bmcl.2017.09.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.09.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.09.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImprovement%252Bin%252Baqueous%252Bsolubility%252Bachieved%252Bvia%252Bsmall%252Bmolecular%252Bchanges%26aulast%3DWalker%26aufirst%3DMichael%2BA.%26date%3D2017%26volume%3D27%26issue%3D23%26spage%3D5100%26epage%3D5108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Zhou</span>, <span class="hlFld-ContribAuthor ">Miaochang  Liu</span>, <span class="hlFld-ContribAuthor ">Song  Sun</span>, <span class="hlFld-ContribAuthor ">En  Yao</span>, <span class="hlFld-ContribAuthor ">Suqin  Liu</span>, <span class="hlFld-ContribAuthor ">Zhiwen  Wu</span>, <span class="hlFld-ContribAuthor ">Jin-Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Yan  Jiang</span>, <span class="hlFld-ContribAuthor ">Jiang  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent reactions (MCRs) of arylmethyl bromides, arylamidines and elemental sulfur toward unsymmetric 3,5-diaryl 1,2,4-thiadiazoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (26)
                                     , 2571-2573. <a href="https://doi.org/10.1016/j.tetlet.2017.05.061" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.05.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.05.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.05.061%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMulticomponent%252Breactions%252B%252528MCRs%252529%252Bof%252Barylmethyl%252Bbromides%25252C%252Barylamidines%252Band%252Belemental%252Bsulfur%252Btoward%252Bunsymmetric%252B3%25252C5-diaryl%252B1%25252C2%25252C4-thiadiazoles%26aulast%3DZhou%26aufirst%3DZhen%26date%3D2017%26volume%3D58%26issue%3D26%26spage%3D2571%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anjaiah  Aitha</span>, <span class="hlFld-ContribAuthor ">Satyanarayana  Yennam</span>, <span class="hlFld-ContribAuthor ">Manoranjan  Behera</span>, <span class="hlFld-ContribAuthor ">Jaya Shree  Anireddy</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of diaziridinyl quinone thiadiazole hybrids via nitrile sulfide cycloaddition reaction as a key step. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (13)
                                     , 1507-1510. <a href="https://doi.org/10.1016/j.tetlet.2016.02.082" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.02.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.02.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.02.082%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bdiaziridinyl%252Bquinone%252Bthiadiazole%252Bhybrids%252Bvia%252Bnitrile%252Bsulfide%252Bcycloaddition%252Breaction%252Bas%252Ba%252Bkey%252Bstep%26aulast%3DAitha%26aufirst%3DAnjaiah%26date%3D2016%26volume%3D57%26issue%3D13%26spage%3D1507%26epage%3D1510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Braddock</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for Testing Immunological Factors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 2091-2203. <a href="https://doi.org/10.1007/978-3-319-05392-9_45" title="DOI URL">https://doi.org/10.1007/978-3-319-05392-9_45</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-05392-9_45&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-05392-9_45%26sid%3Dliteratum%253Aachs%26atitle%3DMethods%252Bfor%252BTesting%252BImmunological%252BFactors%26aulast%3DBraddock%26aufirst%3DMartin%26date%3D2016%26spage%3D2091%26epage%3D2203%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDrug%252BDiscovery%252Band%252BEvaluation%25253A%252BPharmacological%252BAssays%26aulast%3DHock%26aufirst%3DFranz%2BJ.%26date%3D2016%26volume%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A V  Galenko</span>, <span class="hlFld-ContribAuthor ">A F  Khlebnikov</span>, <span class="hlFld-ContribAuthor ">M S  Novikov</span>, <span class="hlFld-ContribAuthor ">V V  Pakalnis</span>, <span class="hlFld-ContribAuthor ">N V  Rostovskii</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in isoxazole chemistry. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Reviews</span><span> <strong>2015,</strong> <em>84 </em>
                                    (4)
                                     , 335-377. <a href="https://doi.org/10.1070/RCR4503" title="DOI URL">https://doi.org/10.1070/RCR4503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1070/RCR4503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1070%2FRCR4503%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Reviews%26atitle%3DRecent%252Badvances%252Bin%252Bisoxazole%252Bchemistry%26aulast%3DGalenko%26aufirst%3DA%2BV%26date%3D2015%26date%3D2015%26volume%3D84%26issue%3D4%26spage%3D335%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Quattropani</span>, <span class="hlFld-ContribAuthor ">Wolfgang H. B.  Sauer</span>, <span class="hlFld-ContribAuthor ">Stefano  Crosignani</span>, <span class="hlFld-ContribAuthor ">Jerome  Dorbais</span>, <span class="hlFld-ContribAuthor ">Patrick  Gerber</span>, <span class="hlFld-ContribAuthor ">Jerome  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Delphine  Marin</span>, <span class="hlFld-ContribAuthor ">Mathilde  Muzerelle</span>, <span class="hlFld-ContribAuthor ">Fanny  Beltran</span>, <span class="hlFld-ContribAuthor ">Anthony  Nichols</span>, <span class="hlFld-ContribAuthor ">Katrin  Georgi</span>, <span class="hlFld-ContribAuthor ">Manfred  Schneider</span>, <span class="hlFld-ContribAuthor ">Pierre-Alain  Vitte</span>, <span class="hlFld-ContribAuthor ">Valerie  Eligert</span>, <span class="hlFld-ContribAuthor ">Laurence  Novo-Perez</span>, <span class="hlFld-ContribAuthor ">Jennifer  Hantson</span>, <span class="hlFld-ContribAuthor ">Sebastien  Nock</span>, <span class="hlFld-ContribAuthor ">Susanna  Carboni</span>, <span class="hlFld-ContribAuthor ">Adriano Luis Soares  de Souza</span>, <span class="hlFld-ContribAuthor ">Jean-François  Arrighi</span>, <span class="hlFld-ContribAuthor ">Ursula  Boschert</span>, <span class="hlFld-ContribAuthor ">Agnes  Bombrun</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore-Based Design of Novel Oxadiazoles as Selective Sphingosine-1-phosphate (S1P) Receptor Agonists with in vivo Efficacy. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (4)
                                     , 688-714. <a href="https://doi.org/10.1002/cmdc.201402557" title="DOI URL">https://doi.org/10.1002/cmdc.201402557</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402557%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPharmacophore-Based%252BDesign%252Bof%252BNovel%252BOxadiazoles%252Bas%252BSelective%252BSphingosine-1-phosphate%252B%252528S1P%252529%252BReceptor%252BAgonists%252Bwith%252Bin%252Bvivo%252BEfficacy%26aulast%3DQuattropani%26aufirst%3DAnna%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D4%26spage%3D688%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caihong  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Yue  Zhu</span>, <span class="hlFld-ContribAuthor ">Jiejie  Deng</span>, <span class="hlFld-ContribAuthor ">Ming-Wei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Emergence of Chinese Drug Discovery Research. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Screening</span><span> <strong>2015,</strong> <em>20 </em>
                                    (3)
                                     , 318-329. <a href="https://doi.org/10.1177/1087057114561950" title="DOI URL">https://doi.org/10.1177/1087057114561950</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1087057114561950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1087057114561950%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Screening%26atitle%3DEmergence%252Bof%252BChinese%252BDrug%252BDiscovery%252BResearch%26aulast%3DZhou%26aufirst%3DCaihong%26date%3D2015%26date%3D2014%26volume%3D20%26issue%3D3%26spage%3D318%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Braddock</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for Testing Immunological Factors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 1-131. <a href="https://doi.org/10.1007/978-3-642-27728-3_45-1" title="DOI URL">https://doi.org/10.1007/978-3-642-27728-3_45-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-27728-3_45-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-27728-3_45-1%26sid%3Dliteratum%253Aachs%26atitle%3DMethods%252Bfor%252BTesting%252BImmunological%252BFactors%26aulast%3DBraddock%26aufirst%3DMartin%26date%3D2015%26date%3D2015%26spage%3D1%26epage%3D131%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DDrug%252BDiscovery%252Band%252BEvaluation%25253A%252BPharmacological%252BAssays%26aulast%3DHock%26aufirst%3DFranz%2BJ.%26date%3D2014%26volume%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Wu  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing-Xiu  Xu</span>, <span class="hlFld-ContribAuthor ">Xiu-Zhen  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Green synthesis of 1,2,4-thiadizoles from thioamides in water using molecular oxygen as an oxidant. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2014,</strong> <em>25 </em>
                                    (11)
                                     , 1499-1502. <a href="https://doi.org/10.1016/j.cclet.2014.05.019" title="DOI URL">https://doi.org/10.1016/j.cclet.2014.05.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2014.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2014.05.019%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DGreen%252Bsynthesis%252Bof%252B1%25252C2%25252C4-thiadizoles%252Bfrom%252Bthioamides%252Bin%252Bwater%252Busing%252Bmolecular%252Boxygen%252Bas%252Ban%252Boxidant%26aulast%3DZhao%26aufirst%3DJin-Wu%26date%3D2014%26volume%3D25%26issue%3D11%26spage%3D1499%26epage%3D1502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariangela  Urbano</span>, <span class="hlFld-ContribAuthor ">Miguel  Guerrero</span>, <span class="hlFld-ContribAuthor ">Hugh  Rosen</span>, <span class="hlFld-ContribAuthor ">Edward  Roberts</span>. </span><span class="cited-content_cbyCitation_article-title">Modulators of the Sphingosine 1-phosphate receptor 1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (23)
                                     , 6377-6389. <a href="https://doi.org/10.1016/j.bmcl.2013.09.058" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DModulators%252Bof%252Bthe%252BSphingosine%252B1-phosphate%252Breceptor%252B1%26aulast%3DUrbano%26aufirst%3DMariangela%26date%3D2013%26volume%3D23%26issue%3D23%26spage%3D6377%26epage%3D6389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yijing  Li</span>, <span class="hlFld-ContribAuthor ">Jingkun  Geng</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Shenghui  Yu</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Thiadiazole-a Promising Structure in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2013,</strong> <em>8 </em>
                                    (1)
                                     , 27-41. <a href="https://doi.org/10.1002/cmdc.201200355" title="DOI URL">https://doi.org/10.1002/cmdc.201200355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201200355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201200355%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThiadiazole-a%252BPromising%252BStructure%252Bin%252BMedicinal%252BChemistry%26aulast%3DLi%26aufirst%3DYijing%26date%3D2013%26date%3D2012%26volume%3D8%26issue%3D1%26spage%3D27%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Jin  Wu</span>, <span class="hlFld-ContribAuthor ">Bingwei V.  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Five-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 257-275. <a href="https://doi.org/10.1016/B978-0-08-099406-2.00010-8" title="DOI URL">https://doi.org/10.1016/B978-0-08-099406-2.00010-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-099406-2.00010-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-099406-2.00010-8%26sid%3Dliteratum%253Aachs%26atitle%3DFive-Membered%252BRing%252BSystems%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2013%26spage%3D257%26epage%3D275%26pub%3DElsevier%26date%3D2013%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of FTY720 (<b>1</b>) and its phosphate (<b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lead compound <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0013.jpeg" id="rightTab-GRAPHIC-d918e1013-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Treatment efficacy of compound <b>4a</b> in mouse EAE. (b) Treatment efficacy of compounds <b>4b</b>, <b>4e</b>, and <b>4m</b> in mouse EAE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedure for the 1,2,4-Thiadiazole Amino Acid Derivatives <b>12</b> and <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <b>7</b>, PdCl<sub>2</sub>(dppf), K<sub>3</sub>PO<sub>4</sub>, 53–97%. (b) <b>9</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, 77–94%. (c) <b>11</b>, NaBH(OAc)<sub>3</sub>, HOAc, 10–60%. (d) <b>13</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, 65–98%. (e) HCl, 80–100%. (f) <b>16</b>, NaBH(OAc)<sub>3</sub>, HOAc, 10–60%.</p></p></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0014.jpeg" id="rightTab-GRAPHIC-d918e1792-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Treatment efficacy of compound <b>17e</b> in mouse EAE. (b) Treatment efficacy of compound <b>17g</b> in mouse EAE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/medium/jm-2011-016107_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0001.jpeg" id="rightTab-GRAPHIC-d918e1820-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Dose-dependent lymphopenia produced by single ascending dose of compound <b>17g</b>. (b) Chronic lymphopenia elicited by repeat dosing of compound <b>17g</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-9/jm2016107/production/images/large/jm-2011-016107_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016107&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84023" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84023" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Compston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coles, A.</span><span> </span><span class="NLM_article-title">Multiple Sclerosis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1221</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1016%2FS0140-6736%2802%2908220-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=11955556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A280%3ADC%252BD383hvVegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2002&pages=1221-1231&author=A.+Compstonauthor=A.+Coles&title=Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple sclerosis</span></div><div class="casAuthors">Compston Alastair; Coles Alasdair</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">9313</span>),
    <span class="NLM_cas:pages">1221-31</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">Multiple sclerosis is the prototype inflammatory autoimmune disorder of the central nervous system and, with a lifetime risk of one in 400, potentially the most common cause of neurological disability in young adults.  As with all complex traits, the disorder results from an interplay between as yet unidentified environmental factors and susceptibility genes.  Together, these factors trigger a cascade of events, involving engagement of the immune system, acute inflammatory injury of axons and glia, recovery of function and structural repair, post-inflammatory gliosis, and neurodegeneration.  The sequential involvement of these processes underlies the clinical course characterised by episodes with recovery, episodes leaving persistent deficits, and secondary progression.  The aim of treatment is to reduce the frequency, and limit the lasting effects, of relapses, relieve symptoms, prevent disability arising from disease progression, and promote tissue repair.  Despite limited success in each of these categories, everyone touched by multiple sclerosis looks for a better dividend from applying an improved understanding of the pathogenesis to clinical management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRIu2mS4c49KqcneEtCi92fW6udTcc2ebbxGVI3RtOLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383hvVegsA%253D%253D&md5=dafa765f3049d15a63843d54643d144e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2802%2908220-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252802%252908220-X%26sid%3Dliteratum%253Aachs%26aulast%3DCompston%26aufirst%3DA.%26aulast%3DColes%26aufirst%3DA.%26atitle%3DMultiple%2520Sclerosis%26jtitle%3DLancet%26date%3D2002%26volume%3D359%26spage%3D1221%26epage%3D1231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Sorbera, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulsat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, E.</span><span> </span><span class="NLM_article-title">Therapeutic Targets for Multiple Sclerosis</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1358%2Fdof.2009.034.05.1364290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSqtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=405-417&author=L.+A.+Sorberaauthor=C.+Dulsatauthor=E.+Rosa&title=Therapeutic+Targets+for+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targets for multiple sclerosis</span></div><div class="casAuthors">Sorbera, L. A.; Dulsat, C.; Rosa, E.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">405-417</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is an inflammatory disorder of the brain and spinal cord in which focal lymphocytic infiltration leads to myelin and axonal damage.  Although first described in the 14th century, MS was untreatable until the 1990s, when interferon beta (IFN-β) reached the market for the first time.  Four different IFNs and glatiramer acetate all obtained regulatory approval in the 1990s, radically influencing the treatment of MS.  Since then, novel strategies have been developed for the treatment of MS, including targeting of leukocyte differentiation mols., costimulatory mols., antiadhesion mols. and chemotaxis; immunomodulatory agents, autologous stem cell transplantation, anti-infectious therapies and strategies for neuroprotection, neurorepair and remyelination have also emerged.  However, there is still no cure for MS and existing treatments serve only to slow disease progression and mitigate symptoms.  The search for effective treatments for MS continues, with researchers focusing on the identification of novel targets for therapeutic intervention.  This article presents those drug targets that are currently under active investigation for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoubXHI5LQzTLVg90H21EOLACvtfcHk0lhyMnn13Qyz2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSqtbnF&md5=3efae49411bad286dd81bbe50565debf</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1358%2Fdof.2009.034.05.1364290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2009.034.05.1364290%26sid%3Dliteratum%253Aachs%26aulast%3DSorbera%26aufirst%3DL.%2BA.%26aulast%3DDulsat%26aufirst%3DC.%26aulast%3DRosa%26aufirst%3DE.%26atitle%3DTherapeutic%2520Targets%2520for%2520Multiple%2520Sclerosis%26jtitle%3DDrugs%2520Future%26date%3D2009%26volume%3D34%26spage%3D405%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): Discovery and Development of an Oral Drug to Treat Multiple Sclerosis</span> <span class="citation_source-journal">Nat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+Discovery+and+Development+of+an+Oral+Drug+to+Treat+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0lhVGz1iGn1mgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520Discovery%2520and%2520Development%2520of%2520an%2520Oral%2520Drug%2520to%2520Treat%2520Multiple%2520Sclerosis%26jtitle%3DNat.%2520Rev.%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lublin, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutter, G.</span><span> </span><span class="NLM_article-title">Effect of Relapses on Development of Residual Deficit in Multiple Sclerosis</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1528</span><span class="NLM_x">–</span> <span class="NLM_lpage">1532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=1528-1532&author=F.+D.+Lublinauthor=M.+Baierauthor=G.+Cutter&title=Effect+of+Relapses+on+Development+of+Residual+Deficit+in+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLublin%26aufirst%3DF.%2BD.%26aulast%3DBaier%26aufirst%3DM.%26aulast%3DCutter%26aufirst%3DG.%26atitle%3DEffect%2520of%2520Relapses%2520on%2520Development%2520of%2520Residual%2520Deficit%2520in%2520Multiple%2520Sclerosis%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D1528%26epage%3D1532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">FTY720: Sphingosine 1-Phosphate Receptor-1 in the Control of Lymphocyte Egress and Endothelial Barrier Function</span> <span class="citation_source-journal">Am. J. Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1111%2Fj.1600-6143.2004.00476.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=15196057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFGksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=1019-1025&author=V.+Brinkmannauthor=J.+G.+Cysterauthor=T.+Hla&title=FTY720%3A+Sphingosine+1-Phosphate+Receptor-1+in+the+Control+of+Lymphocyte+Egress+and+Endothelial+Barrier+Function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function</span></div><div class="casAuthors">Brinkmann, Volker; Cyster, Jason G.; Hla, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Transplantation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1019-1025</span>CODEN:
                <span class="NLM_cas:coden">AJTMBR</span>;
        ISSN:<span class="NLM_cas:issn">1600-6135</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The novel immunomodulator FTY720 is effective in exptl. models of transplantation and autoimmunity, and is currently undergoing Phase III clin. trials for prevention of kidney graft rejection.  In contrast to conventional immunosuppressants, FTY720 does not impair T- and B-cell activation, proliferation and effector function, but interferes with cell traffic between lymphoid organs and blood.  The mol. basis for the mode of action of the drug has only recently been established.  FTY720, after phosphorylation, acts as a high-affinity agonist at the G protein-coupled sphingosine 1-phosphate receptor-1 (S1P1) on thymocytes and lymphocytes, thereby inducing aberrant internalization of the receptor.  This renders the cells unresponsive to the serum lipid sphingosine 1-phosphate (S1P), depriving them from an obligatory signal to egress from lymphoid organs.  As a consequence, lymphocytes are unable to recirculate to peripheral inflammatory tissues and graft sites but remain functional in the lymphoid compartment.  In addn. to the effects on lymphocyte recirculation, the drug acts on endothelial cells and preserves vascular integrity by enhancing adherens junction assembly and endothelial barrier function.  The available data establish S1P1 as a key target for FTY720, and further point to therapeutically relevant effects of the drug on lymphocytes and vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpucC2_LbDXlrVg90H21EOLACvtfcHk0lhVGz1iGn1mgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFGksLw%253D&md5=c18b89e72deeb928d68dabbca0f7ad37</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-6143.2004.00476.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-6143.2004.00476.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DFTY720%253A%2520Sphingosine%25201-Phosphate%2520Receptor-1%2520in%2520the%2520Control%2520of%2520Lymphocyte%2520Egress%2520and%2520Endothelial%2520Barrier%2520Function%26jtitle%3DAm.%2520J.%2520Transplant.%26date%3D2004%26volume%3D4%26spage%3D1019%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Miron, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarjour, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliven, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720) Enhances Remyelination following Demyelination of Organotypic Cerebellar Slices</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">2682</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.2353%2Fajpath.2010.091234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=20413685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2010&pages=2682-2694&author=V.+E.+Mironauthor=S.+K.+Ludwinauthor=P.+J.+Darlingtonauthor=A.+A.+Jarjourauthor=B.+Solivenauthor=T.+E.+Kennedyauthor=J.+P.+Antel&title=Fingolimod+%28FTY720%29+Enhances+Remyelination+following+Demyelination+of+Organotypic+Cerebellar+Slices"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices</span></div><div class="casAuthors">Miron, Veronique E.; Ludwin, Samuel K.; Darlington, Peter J.; Jarjour, Andrew A.; Soliven, Betty; Kennedy, Timothy E.; Antel, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2682-2694</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Remyelination, which occurs subsequent to demyelination, contributes to functional recovery and is mediated by oligodendrocyte progenitor cells (OPCs) that have differentiated into myelinating cells.  Therapeutics that impact remyelination in the CNS could be crit. determinants of long-term functional outcome in multiple sclerosis (MS).  Fingolimod is a S1P receptor modulator in MS clin. trials due to systemic anti-inflammatory properties, yet may impact cells within the CNS by crossing the blood-brain barrier.  Previous studies using isolated dissocd. cultures indicate that neural cells express S1P receptors and respond to receptor engagement.  Our objective was to assess the effects of fingolimod on myelinrelated processes within a multicellular environment that maintains physiol. cell-cell interactions, using organotypic cerebellar slice cultures.  Fingolimod treatment had no impact on myelin under basal conditions.  Fingolimod treatment subsequent to lysolecithin-induced demyelination enhanced remyelination and process extension by OPCs and mature oligodendrocytes, while increasing microglia nos. and immunoreactivity for the astrocytic marker glial fibrillary acidic protein.  The no. of phagocytosing microglia was not increased by fingolimod.  Using S1P receptor specific agonists and antagonists, we detd. that fingolimod-induced effects on remyelination and astrogliosis were mediated primarily through S1P3 and S1P5, whereas enhanced microgliosis was mediated through S1P1 and S1P5.  Taken together, these data demonstrate that fingolimod modulates multiple neuroglial cell responses, resulting in enhanced remyelination in organotypic slice cultures that maintain the complex cellular interactions of the mammalian brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradvge9335h7Vg90H21EOLACvtfcHk0lhVGz1iGn1mgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D&md5=6e7efa55ed7482a64dad66c6ec384de8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.091234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.091234%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DDarlington%26aufirst%3DP.%2BJ.%26aulast%3DJarjour%26aufirst%3DA.%2BA.%26aulast%3DSoliven%26aufirst%3DB.%26aulast%3DKennedy%26aufirst%3DT.%2BE.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26atitle%3DFingolimod%2520%2528FTY720%2529%2520Enhances%2520Remyelination%2520following%2520Demyelination%2520of%2520Organotypic%2520Cerebellar%2520Slices%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D176%26spage%3D2682%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Choi, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Astrocytic Sphingosine 1-Phosphate (S1P) Receptor Subtype 1 Signalling Influences Levels of S1P and Cytokines during Experimental Autoimmune Encephalomyelitis and Fingolimod (FTY720) Intervention</span> <span class="citation_source-journal">Mult. Scler.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">S58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=S58&author=J.+W.+Choiauthor=D.+Herrauthor=G.+Kennedyauthor=J.+Chun&title=Astrocytic+Sphingosine+1-Phosphate+%28S1P%29+Receptor+Subtype+1+Signalling+Influences+Levels+of+S1P+and+Cytokines+during+Experimental+Autoimmune+Encephalomyelitis+and+Fingolimod+%28FTY720%29+Intervention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DHerr%26aufirst%3DD.%26aulast%3DKennedy%26aufirst%3DG.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DAstrocytic%2520Sphingosine%25201-Phosphate%2520%2528S1P%2529%2520Receptor%2520Subtype%25201%2520Signalling%2520Influences%2520Levels%2520of%2520S1P%2520and%2520Cytokines%2520during%2520Experimental%2520Autoimmune%2520Encephalomyelitis%2520and%2520Fingolimod%2520%2528FTY720%2529%2520Intervention%26jtitle%3DMult.%2520Scler.%26date%3D2009%26volume%3D15%26spage%3DS58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of Lymphocyte Trafficking by Sphingosine-1 Phosphate Receptor Agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+Lymphocyte+Trafficking+by+Sphingosine-1+Phosphate+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520Lymphocyte%2520Trafficking%2520by%2520Sphingosine-1%2520Phosphate%2520Receptor%2520Agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The Immune Modulator FTY720 Targets Sphingosine-1-Phosphate Receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+Immune+Modulator+FTY720+Targets+Sphingosine-1-Phosphate+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520Immune%2520Modulator%2520FTY720%2520Targets%2520Sphingosine-1-Phosphate%2520Receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Verzijl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span> </span><span class="NLM_article-title">Sphingosine-1-Phosphate Receptors: Zooming in on Ligand-Induced Intracellular Trafficking and Its Functional Implications</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=99-104&author=D.+Verzijlauthor=S.+L.+M.+Petersauthor=A.+E.+Alewijnse&title=Sphingosine-1-Phosphate+Receptors%3A+Zooming+in+on+Ligand-Induced+Intracellular+Trafficking+and+Its+Functional+Implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerzijl%26aufirst%3DD.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26atitle%3DSphingosine-1-Phosphate%2520Receptors%253A%2520Zooming%2520in%2520on%2520Ligand-Induced%2520Intracellular%2520Trafficking%2520and%2520Its%2520Functional%2520Implications%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D29%26spage%3D99%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte Egress from Thymus and Peripheral Lymphoid Organs Is Dependent on S1P Receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+Egress+from+Thymus+and+Peripheral+Lymphoid+Organs+Is+Dependent+on+S1P+Receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520Egress%2520from%2520Thymus%2520and%2520Peripheral%2520Lymphoid%2520Organs%2520Is%2520Dependent%2520on%2520S1P%2520Receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Expression of the Sphingosine-1-Phosphate, S1P<sub>1</sub>, on T-Cells Controls Thymic Emigration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15396</span><span class="NLM_x">–</span> <span class="NLM_lpage">15401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15396-15401&author=M.+L.+Allendeauthor=J.+L.+Dreierauthor=S.+Mandalaauthor=R.+L.+Proia&title=Expression+of+the+Sphingosine-1-Phosphate%2C+S1P1%2C+on+T-Cells+Controls+Thymic+Emigration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DDreier%26aufirst%3DJ.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DExpression%2520of%2520the%2520Sphingosine-1-Phosphate%252C%2520S1P1%252C%2520on%2520T-Cells%2520Controls%2520Thymic%2520Emigration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15396%26epage%3D15401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Mizugishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Essential Role for Sphingosine Kinases in Neural and Vascular Development</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">11113</span><span class="NLM_x">–</span> <span class="NLM_lpage">11121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1128%2FMCB.25.24.11113-11121.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=16314531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlektr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=11113-11121&author=K.+Mizugishiauthor=T.+Yamashitaauthor=A.+Oliveraauthor=G.+F.+Millerauthor=S.+Spiegelauthor=R.+L.+Proia&title=Essential+Role+for+Sphingosine+Kinases+in+Neural+and+Vascular+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Essential role for sphingosine kinases in neural and vascular development</span></div><div class="casAuthors">Mizugishi, Kiyomi; Yamashita, Tadashi; Olivera, Ana; Miller, Georgina F.; Spiegel, Sarah; Proia, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11113-11121</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate (S1P), an important sphingolipid metabolite, regulates diverse cellular processes, including cell survival, growth, and differentiation.  Here we show that S1P signaling is crit. for neural and vascular development.  Sphingosine kinase-null mice exhibited a deficiency of S1P which severely disturbed neurogenesis, including neural tube closure, and angiogenesis and caused embryonic lethality.  A dramatic increase in apoptosis and a decrease in mitosis were seen in the developing nervous system.  S1P1 receptor-null mice also showed severe defects in neurogenesis, indicating that the mechanism by which S1P promotes neurogenesis is, in part, signaling from the S1P1 receptor.  Thus, S1P joins a growing list of signaling mols., such as vascular endothelial growth factor, which regulate the functionally intertwined pathways of angiogenesis and neurogenesis.  Our findings also suggest that exploitation of this potent neuronal survival pathway could lead to the development of novel therapeutic approaches for neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1FtMYvASa3bVg90H21EOLACvtfcHk0lhmUdVJWgxO6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlektr3N&md5=3757d4b2b18d6f9e4526df92c7a595d4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.24.11113-11121.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.24.11113-11121.2005%26sid%3Dliteratum%253Aachs%26aulast%3DMizugishi%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DOlivera%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DG.%2BF.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DEssential%2520Role%2520for%2520Sphingosine%2520Kinases%2520in%2520Neural%2520and%2520Vascular%2520Development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D11113%26epage%3D11121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kovarik, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riviere, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldwater, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R. L.</span><span> </span><span class="NLM_article-title">The Effect on Heart Rate of Combining Single-Dose Fingolimod with Steady-State Atenolol or Diltiazem in Healthy Subjects</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=457-463&author=J.+M.+Kovarikauthor=M.+Luauthor=G.+Riviereauthor=I.+Barbetauthor=S.+Matonauthor=D.+R.+Goldwaterauthor=R.+L.+Schmouder&title=The+Effect+on+Heart+Rate+of+Combining+Single-Dose+Fingolimod+with+Steady-State+Atenolol+or+Diltiazem+in+Healthy+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKovarik%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DRiviere%26aufirst%3DG.%26aulast%3DBarbet%26aufirst%3DI.%26aulast%3DMaton%26aufirst%3DS.%26aulast%3DGoldwater%26aufirst%3DD.%2BR.%26aulast%3DSchmouder%26aufirst%3DR.%2BL.%26atitle%3DThe%2520Effect%2520on%2520Heart%2520Rate%2520of%2520Combining%2520Single-Dose%2520Fingolimod%2520with%2520Steady-State%2520Atenolol%2520or%2520Diltiazem%2520in%2520Healthy%2520Subjects%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D64%26spage%3D457%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimarco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastien, M.-C.</span><span> </span><span class="NLM_article-title">FTY720: Placebo-Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1177%2F0091270006289853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=16855074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1Kjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=895-904&author=R.+Schmouderauthor=D.+Serraauthor=Y.+Wangauthor=J.+M.+Kovarikauthor=J.+Dimarcoauthor=T.+L.+Huntauthor=M.-C.+Bastien&title=FTY720%3A+Placebo-Controlled+Study+of+the+Effect+on+Cardiac+Rate+and+Rhythm+in+Healthy+Subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720: placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects</span></div><div class="casAuthors">Schmouder, Robert; Serra, Denise; Wang, Yibin; Kovarik, John M.; DiMarco, John; Hunt, Thomas L.; Bastien, Marie-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">895-904</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The purpose of this double-blind, placebo-controlled study was to measure the effects of FTY720, a novel immunomodulator, on heart rate and rhythm in healthy volunteers.  Subjects (n = 66) were randomized to FTY720 1.25 mg or 5 mg or placebo administered once daily for 7 days.  Continuous telemetry revealed an acute, dose-dependent decrease in mean heart rate (10-bpm decrease vs. placebo) following the first dose of FTY720, with a nadir generally 4 h postdose.  Although a persistent FTY720-related decrease in heart rate was measured from day 2 to day 7, addnl. doses of FTY720 after day 2 resulted in no further incremental decreases.  Mean PR interval increased by approx. 8 to 10 ms in FTY720-treated subjects on day 1.  FTY720 did not increase the QRS or QT interval.  These results confirm that the first dose of FTY720 has a mild to moderate neg. chronotropic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB7QxNA7zcX7Vg90H21EOLACvtfcHk0lgQuHdfB4yv2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1Kjtrg%253D&md5=4b32061d569b5dc4e7b5030e52feef0e</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1177%2F0091270006289853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270006289853%26sid%3Dliteratum%253Aachs%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DSerra%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKovarik%26aufirst%3DJ.%2BM.%26aulast%3DDimarco%26aufirst%3DJ.%26aulast%3DHunt%26aufirst%3DT.%2BL.%26aulast%3DBastien%26aufirst%3DM.-C.%26atitle%3DFTY720%253A%2520Placebo-Controlled%2520Study%2520of%2520the%2520Effect%2520on%2520Cardiac%2520Rate%2520and%2520Rhythm%2520in%2520Healthy%2520Subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D895%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune Cell Regulation and Cardiovascular Effects of Sphingosine-1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tiamauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+Cell+Regulation+and+Cardiovascular+Effects+of+Sphingosine-1-Phosphate+Receptor+Agonists+in+Rodents+Are+Mediated+via+Distinct+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0lgQuHdfB4yv2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTiam%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520Cell%2520Regulation%2520and%2520Cardiovascular%2520Effects%2520of%2520Sphingosine-1-Phosphate%2520Receptor%2520Agonists%2520in%2520Rodents%2520Are%2520Mediated%2520via%2520Distinct%2520Receptor%2520Subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, Respectively, Regulate Lymphocyte Recirculation and Heart Rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.-Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-Phosphate+%28S1P%29+Receptor+Subtypes+S1P1+and+S1P3%2C+Respectively%2C+Regulate+Lymphocyte+Recirculation+and+Heart+Rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-Phosphate%2520%2528S1P%2529%2520Receptor%2520Subtypes%2520S1P1%2520and%2520S1P3%252C%2520Respectively%252C%2520Regulate%2520Lymphocyte%2520Recirculation%2520and%2520Heart%2520Rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enosawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeyoshi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span> </span><span class="NLM_article-title">KRP-203, a Novel Synthetic Immunosuppressant, Prolongs Graft Survival and Attenuates Chronic Rejection in Rat Skin and Heart Allografts</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=222-229&author=H.+Shimizuauthor=M.+Takahashiauthor=T.+Kanekoauthor=T.+Murakamiauthor=Y.+Hakamataauthor=S.+Kudouauthor=T.+Kishiauthor=K.+Fukuchiauthor=S.+Iwanamiauthor=K.+Kuriyamaauthor=T.+Yasueauthor=S.+Enosawaauthor=K.+Matsumotoauthor=I.+Takeyoshiauthor=Y.+Morishitaauthor=E.+Kobayashi&title=KRP-203%2C+a+Novel+Synthetic+Immunosuppressant%2C+Prolongs+Graft+Survival+and+Attenuates+Chronic+Rejection+in+Rat+Skin+and+Heart+Allografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DHakamata%26aufirst%3DY.%26aulast%3DKudou%26aufirst%3DS.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DFukuchi%26aufirst%3DK.%26aulast%3DIwanami%26aufirst%3DS.%26aulast%3DKuriyama%26aufirst%3DK.%26aulast%3DYasue%26aufirst%3DT.%26aulast%3DEnosawa%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTakeyoshi%26aufirst%3DI.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DE.%26atitle%3DKRP-203%252C%2520a%2520Novel%2520Synthetic%2520Immunosuppressant%252C%2520Prolongs%2520Graft%2520Survival%2520and%2520Attenuates%2520Chronic%2520Rejection%2520in%2520Rat%2520Skin%2520and%2520Heart%2520Allografts%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D222%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, F. L. S.</span><span> </span><span class="NLM_article-title">Quantitative Determination of BAF312, a S1P-R Modulator, in Human Urine by LC–MS/MS: Prevention and Recovery of Lost Analyte Due to Container Surface Adsorption</span> <span class="citation_source-journal">J. Chromatogr. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">878</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1016%2Fj.jchromb.2009.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=20097141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1yhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=878&publication_year=2010&pages=583-589&author=W.+Liauthor=S.+Luoauthor=H.+T.+Smithauthor=F.+L.+S.+Tse&title=Quantitative+Determination+of+BAF312%2C+a+S1P-R+Modulator%2C+in+Human+Urine+by+LC%E2%80%93MS%2FMS%3A+Prevention+and+Recovery+of+Lost+Analyte+Due+to+Container+Surface+Adsorption"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative determination of BAF312, a S1P-R modulator, in human urine by LC-MS/MS: Prevention and recovery of lost analyte due to container surface adsorption</span></div><div class="casAuthors">Li, Wenkui; Luo, Suyi; Smith, Harold T.; Tse, Francis L. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">878</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">583-589</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Analyte loss due to non-specific binding, esp. container surface adsorption, is not uncommon in the quant. anal. of urine samples.  In developing a sensitive LC-MS/MS method for the detn. of a drug candidate, BAF312, in human urine, a simple procedure was outlined for identification, confirmation and prevention of analyte non-specific binding to a container surface and to recover the non-specific loss' of an analyte, if no transfer has occurred to the original urine samples.  Non-specific binding or container surface adsorption can be quickly identified by using freshly spiked urine calibration stds. and pre-pooled QC samples during a LC-MS/MS feasibility run.  The resulting low recovery of an analyte in urine samples can be prevented through the use of additives, such as the non-ionic surfactant Tween-80, CHAPS and others, to the container prior to urine sample collection.  If the urine samples have not been transferred from the bulk container, the non-specific binding' of an analyte to the container surface can be reversed by the addn. of a specified amt. of CHAPS, Tween-80 or bovine serum albumin, followed by appropriate mixing.  Among the above agents, Tween-80 is the most cost-effective.  β-Cyclodextrin may be suitable in stabilizing the analyte of interest in urine via pre-treating the matrix with the agent.  However, post-addn. of β-cyclodextrin to untreated urine samples does not recover the lost' analyte due to non-specific binding or container surface adsorption.  In the case of BAF312, a dynamic range of 0.0200-20.0 ng/mL in human urine was validated with an overall accuracy and precision for QC sample results ranging from -3.2 to 5.1% (bias) and 3.9 to 10.2% (CV), resp.  Pre- and post-addn. of 0.5% (vol./vol.) Tween-80 to the container provided excellent overall analyte recovery and minimal MS signal suppression when a liq.-liq. extn. in combination with an isocratic LC sepn. was employed.  The compd. was stable in 0.5% Tween-80 treated human urine QC samples for at least 24 h at room temp., after three freeze/thaw cycles with storage at ≤-60 °C and for at least 3 mo when stored at ≤-60 °C.  The current work could serve as a simple example in trouble shooting non-specific binding or container surface adsorption in quant. anal. of urine samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3wQU6DKpY97Vg90H21EOLACvtfcHk0lgXURltjrfoDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1yhsrw%253D&md5=40c0794ce5595b9a129b14645e6a0be9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2009.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2009.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DTse%26aufirst%3DF.%2BL.%2BS.%26atitle%3DQuantitative%2520Determination%2520of%2520BAF312%252C%2520a%2520S1P-R%2520Modulator%252C%2520in%2520Human%2520Urine%2520by%2520LC%25E2%2580%2593MS%252FMS%253A%2520Prevention%2520and%2520Recovery%2520of%2520Lost%2520Analyte%2520Due%2520to%2520Container%2520Surface%2520Adsorption%26jtitle%3DJ.%2520Chromatogr.%2520B%26date%3D2010%26volume%3D878%26spage%3D583%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menuhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P<sub>1</sub> Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menuhartauthor=C.+Mullerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-Imino-thiazolidin-4-one+Derivatives+as+Potent%2C+Orally+Active+S1P1+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenuhart%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-Imino-thiazolidin-4-one%2520Derivatives%2520as%2520Potent%252C%2520Orally%2520Active%2520S1P1%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Buzard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Recent Progress in the Development of Selective S1P<sub>1</sub> Receptor Agonists for the Treatment of Inflammatory and Autoimmune Disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1517%2F13543776.18.10.1141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1141-1159&author=D.+Buzardauthor=J.+Thatteauthor=M.+Lernerauthor=J.+Edwardsauthor=R.+M.+Jones&title=Recent+Progress+in+the+Development+of+Selective+S1P1+Receptor+Agonists+for+the+Treatment+of+Inflammatory+and+Autoimmune+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders</span></div><div class="casAuthors">Buzard, Daniel J.; Thatte, Jayant; Lerner, Michael; Edwards, Jeffrey; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1141-1159</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The sphingosine-1-phosphate receptor 1 (S1P1) belongs to the endothelial differentiation gene family of G-protein-coupled receptors involved in embryonic development, cellular differentiation and survival, adherence and tight junction assembly, and leukocyte trafficking.  In vivo S1P1 is required for egress of thymocytes into the blood and of naive lymphocytes from secondary lymphoid organs back into the lymph.  Downregulation of S1P1 disrupts lymphocyte migration, tissue homing and recirculation.  To explore the immunomodulatory potential of S1P1, pharma is developing S1P1-selective agonists for treating autoimmune and inflammatory disorders.  FTY720 (fingolimod, Novartis AG), a nonselective S1P1 agonist that induces sustained lymphopenia, is a promising pseudo-lipid aminodiol prodrug that has been shown in preclin. and early clin. trials to be effective in suppressing various autoimmune conditions and to aid in acute organ transplant, and is currently in pivotal Phase III clin. trials for relapsing-remitting multiple sclerosis.  In this review article, we outline recent advances made in the discovery and patenting of new small-mol. S1P1 selective agonists and summarize a rapidly growing body of intellectual property.  Fingolimod-like S1P1 agonists with a novel mechanism of action have emerged as promising immunosuppressants.  S1P1 agonists induce T-cell sequestration in lymph nodes and Peyer's patches, diminishing their ability to reach distant sites and cause pathol.  Preclin. studies have already provided preliminary evidence that low-dose treatment with fingolimod in conjunction with subtherapeutic doses of cyclosporin A and tacrolimus enable potent immunosuppression in the absence of immediately serious side effects.  Future efforts will det. whether S1P1 agonists do indeed synergize with existing DMAs to create new mutidrug paradigms with superior efficacy and safety for the treatment of autoimmune diseases and the prevention of organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoio59l2iXb2rVg90H21EOLACvtfcHk0lgXURltjrfoDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK&md5=fe911f7d9d3fb961c7df50663bffc245</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.10.1141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.10.1141%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DLerner%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520Selective%2520S1P1%2520Receptor%2520Agonists%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520and%2520Autoimmune%2520Disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1141%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budhu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. M.</span><span> </span><span class="NLM_article-title">2-Aryl(pyrrolidin-4-yl)acetic Acids Are Potent Agonists of Sphingosine-1-Phosphate (S1P) Receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3564</span><span class="NLM_x">–</span> <span class="NLM_lpage">3568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3564-3568&author=L.+Yanauthor=R.+Budhuauthor=P.+Huoauthor=C.+L.+Lynchauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=S.+M.+Mandala&title=2-Aryl%28pyrrolidin-4-yl%29acetic+Acids+Are+Potent+Agonists+of+Sphingosine-1-Phosphate+%28S1P%29+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DBudhu%26aufirst%3DR.%26aulast%3DHuo%26aufirst%3DP.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3D2-Aryl%2528pyrrolidin-4-yl%2529acetic%2520Acids%2520Are%2520Potent%2520Agonists%2520of%2520Sphingosine-1-Phosphate%2520%2528S1P%2529%2520Receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3564%26epage%3D3568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. M.</span><span> </span><span class="NLM_article-title">Discovery of 3-Arylpropionic Acids as Potent Agonists of Sphingosine-1-Phosphate Receptor-1 (S1P<sub>1</sub>) with High Selectivity against All Other Known S1P Receptor Subtypes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3679</span><span class="NLM_x">–</span> <span class="NLM_lpage">3683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3679-3683&author=L.+Yanauthor=P.+Huoauthor=G.+Dohertyauthor=L.+Tothauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=E.+Quackenbushauthor=A.+Wickhamauthor=S.+M.+Mandala&title=Discovery+of+3-Arylpropionic+Acids+as+Potent+Agonists+of+Sphingosine-1-Phosphate+Receptor-1+%28S1P1%29+with+High+Selectivity+against+All+Other+Known+S1P+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DHuo%26aufirst%3DP.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DToth%26aufirst%3DL.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DWickham%26aufirst%3DA.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%25203-Arylpropionic%2520Acids%2520as%2520Potent%2520Agonists%2520of%2520Sphingosine-1-Phosphate%2520Receptor-1%2520%2528S1P1%2529%2520with%2520High%2520Selectivity%2520against%2520All%2520Other%2520Known%2520S1P%2520Receptor%2520Subtypes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3679%26epage%3D3683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vachal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Highly Selective and Potent Agonists of Sphingosine-1-Phosphate 1 (S1P<sub>1</sub>) Receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3684</span><span class="NLM_x">–</span> <span class="NLM_lpage">3687</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3684-3687&author=P.+Vachalauthor=L.+M.+Tothauthor=J.+J.+Haleauthor=L.+Yanauthor=S.+G.+Millsauthor=G.+L.+Chrebetauthor=C.+A.+Keohaneauthor=R.+Hajduauthor=J.+A.+Milliganauthor=M.+J.+Rosenbachauthor=S.+Mandala&title=Highly+Selective+and+Potent+Agonists+of+Sphingosine-1-Phosphate+1+%28S1P1%29+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DToth%26aufirst%3DL.%2BM.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChrebet%26aufirst%3DG.%2BL.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DHighly%2520Selective%2520and%2520Potent%2520Agonists%2520of%2520Sphingosine-1-Phosphate%25201%2520%2528S1P1%2529%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3684%26epage%3D3687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. M.</span><span> </span><span class="NLM_article-title">SAR Studies of 3-Arylpropionic Acids as Potent and Selective Agonists of Sphingosine-1-Phosphate Receptor-1 (S1P<sub>1</sub>) with Enhanced Pharmacokinetic Properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">831</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=828-831&author=L.+Yanauthor=P.+Huoauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=S.+M.+Mandala&title=SAR+Studies+of+3-Arylpropionic+Acids+as+Potent+and+Selective+Agonists+of+Sphingosine-1-Phosphate+Receptor-1+%28S1P1%29+with+Enhanced+Pharmacokinetic+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DHuo%26aufirst%3DP.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3DSAR%2520Studies%2520of%25203-Arylpropionic%2520Acids%2520as%2520Potent%2520and%2520Selective%2520Agonists%2520of%2520Sphingosine-1-Phosphate%2520Receptor-1%2520%2528S1P1%2529%2520with%2520Enhanced%2520Pharmacokinetic%2520Properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D828%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Deng, G.; Lin, X.; Meng, Q.; Ren, F.; Xiang, J.; Xu, H.; Zhao, B.; Zhang, H.</span><span> </span><span class="NLM_article-title">Preparation of 5-Membered Heteroaryl Derivatives as Sphingosine 1-Phosphate Receptor Agonists</span>. WO2010148649(A1),<span class="NLM_x"> </span><span class="NLM_year">2010</span>. Mouse experimental autoimmune encephalomyelitis (EAE) data are unpublished results from this laboratory.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=G.+Deng&author=X.+Lin&author=Q.+Meng&author=F.+Ren&author=J.+Xiang&author=H.+Xu&author=B.+Zhao&author=H.+Zhang&title=Preparation+of+5-Membered+Heteroaryl+Derivatives+as+Sphingosine+1-Phosphate+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DG.%26atitle%3DPreparation%2520of%25205-Membered%2520Heteroaryl%2520Derivatives%2520as%2520Sphingosine%25201-Phosphate%2520Receptor%2520Agonists%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">Unpublished results from this laboratory. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental procedure for the mouse CNS penetration study.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lan, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weliky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, E. C.</span><span> </span><span class="NLM_article-title">Metabolic Studies with <i>trans</i>-5-Amino-3-[2-5-nitro-2-furyl]vinyl]-1,2,4-[5-<sup>14</sup>C]oxadiazole (SQ18,506): 1. Reductive Cleavage of the 1,2,4-Oxadiazole Ring</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1973&pages=97-102&author=S.+J.+Lanauthor=I.+Welikyauthor=E.+C.+Schreiber&title=Metabolic+Studies+with+trans-5-Amino-3-%5B2-5-nitro-2-furyl%5Dvinyl%5D-1%2C2%2C4-%5B5-14C%5Doxadiazole+%28SQ18%2C506%29%3A+1.+Reductive+Cleavage+of+the+1%2C2%2C4-Oxadiazole+Ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DS.%2BJ.%26aulast%3DWeliky%26aufirst%3DI.%26aulast%3DSchreiber%26aufirst%3DE.%2BC.%26atitle%3DMetabolic%2520Studies%2520with%2520trans-5-Amino-3-%255B2-5-nitro-2-furyl%255Dvinyl%255D-1%252C2%252C4-%255B5-14C%255Doxadiazole%2520%2528SQ18%252C506%2529%253A%25201.%2520Reductive%2520Cleavage%2520of%2520the%25201%252C2%252C4-Oxadiazole%2520Ring%26jtitle%3DXenobiotica%26date%3D1973%26volume%3D3%26spage%3D97%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span> </span><span class="NLM_article-title">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+Reactions+of+Five-Membered+Aromatic+Heterocyclic+Rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0lh5BOpuz_oBJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520Reactions%2520of%2520Five-Membered%2520Aromatic%2520Heterocyclic%2520Rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sendzik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, H. C.</span><span> </span><span class="NLM_article-title">Environmentally Friendly and Efficient: Iron-Mediated Reduction of 3-Methyl-5-aryl-1,2,4-oxadiazoles to Benzamidines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">8697</span><span class="NLM_x">–</span> <span class="NLM_lpage">8700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=8697-8700&author=M.+Sendzikauthor=H.+C.+Hui&title=Environmentally+Friendly+and+Efficient%3A+Iron-Mediated+Reduction+of+3-Methyl-5-aryl-1%2C2%2C4-oxadiazoles+to+Benzamidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DH.%2BC.%26atitle%3DEnvironmentally%2520Friendly%2520and%2520Efficient%253A%2520Iron-Mediated%2520Reduction%2520of%25203-Methyl-5-aryl-1%252C2%252C4-oxadiazoles%2520to%2520Benzamidines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D8697%26epage%3D8700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bird, C. W.</span><span> </span><span class="NLM_article-title">A New Aromaticity Index and Its Application to Five-membered Ring Heterocycles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1409</span><span class="NLM_x">–</span> <span class="NLM_lpage">1414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1016%2FS0040-4020%2801%2996543-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADyaL2MXlsVWjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1985&pages=1409-1414&author=C.+W.+Bird&title=A+New+Aromaticity+Index+and+Its+Application+to+Five-membered+Ring+Heterocycles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">A new aromaticity index and its application to five-membered ring heterocycles</span></div><div class="casAuthors">Bird, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1409-14</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">A new index of arom. character has been devised based upon a statistical evaluation of the deviations in peripheral bond orders.  The latter can be derived readily from exptl. detd. bond lengths.  The utility of this index is exemplified by its application to five-membered ring heterocycles and their mesoionic derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2uSjjYeOflLVg90H21EOLACvtfcHk0lh5BOpuz_oBJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlsVWjtLc%253D&md5=36fda67f5c5cfe606bc49eb69f86e16f</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2996543-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252996543-3%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DC.%2BW.%26atitle%3DA%2520New%2520Aromaticity%2520Index%2520and%2520Its%2520Application%2520to%2520Five-membered%2520Ring%2520Heterocycles%26jtitle%3DTetrahedron%26date%3D1985%26volume%3D41%26spage%3D1409%26epage%3D1414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bird, C. W.</span><span> </span><span class="NLM_article-title">The Application of a New Aromaticity Index to Six-Membered Ring Heterocycles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1986&pages=89-92&author=C.+W.+Bird&title=The+Application+of+a+New+Aromaticity+Index+to+Six-Membered+Ring+Heterocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DC.%2BW.%26atitle%3DThe%2520Application%2520of%2520a%2520New%2520Aromaticity%2520Index%2520to%2520Six-Membered%2520Ring%2520Heterocycles%26jtitle%3DTetrahedron%26date%3D1986%26volume%3D42%26spage%3D89%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">S1P<sub>1</sub> FRET assay was conducted according to the manufacturer’s protocol (catalog no. K1520, Invitrogen, Carlsbad, CA).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">S1P<sub>3</sub> FRET assay was conducted according to the manufacturer’s protocol (catalog no. K1713, Invitrogen, Carlsbad, CA).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and Computational Approaches To Estimate Solubility and Permeability in Drug Discovery and Development Settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+Computational+Approaches+To+Estimate+Solubility+and+Permeability+in+Drug+Discovery+and+Development+Settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lh5BOpuz_oBJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520Computational%2520Approaches%2520To%2520Estimate%2520Solubility%2520and%2520Permeability%2520in%2520Drug%2520Discovery%2520and%2520Development%2520Settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Fessey, R. E.; Austin, R. P.; Barton, P.; Davis, A. M.; Wenlock, M. C.</span><span> </span><span class="NLM_article-title">The Role of Plasma Protein Binding in Drug Discovery</span>. In  <span class="citation_source-book">Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies</span>, LogP2004: 3rd Lipophilicity Symposium, Zurich, Switzerland, Feb 29–Mar 4, 2004; <span class="NLM_contrib-group">Testa, B.</span>, <span class="NLM_etal">et al.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1002%2F9783906390468.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=119-141&author=R.+E.+Fessey&author=R.+P.+Austin&author=P.+Barton&author=A.+M.+Davis&author=M.+C.+Wenlockauthor=B.+Testa&title=Pharmacokinetic+Profiling+in+Drug+Research%3A+Biological%2C+Physicochemical%2C+and+Computational+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2F9783906390468.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783906390468.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DFessey%26aufirst%3DR.%2BE.%26atitle%3DThe%2520Role%2520of%2520Plasma%2520Protein%2520Binding%2520in%2520Drug%2520Discovery%26btitle%3DPharmacokinetic%2520Profiling%2520in%2520Drug%2520Research%253A%2520Biological%252C%2520Physicochemical%252C%2520and%2520Computational%2520Strategies%26aulast%3DTesta%26aufirst%3DB.%26pub%3DWiley-VCH%26date%3D2006%26spage%3D119%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><div class="note"><p class="first last">For EAE protocol, refer to the following: </p></div><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. Z.</span><span> </span><span class="NLM_article-title">Crucial Role of Interleukin-7 in T Helper Type 17 Survival and Expansion in Autoimmune Disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm2016107&amp;key=10.1038%2Fnm.2077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm2016107&amp;key=20062065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm2016107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjsVaqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=191-197&author=X.+Liuauthor=L.+Leungauthor=C.+Wangauthor=Z.+Tanauthor=J.+Wangauthor=T.+B.+Guoauthor=L.+Fangauthor=Y.+Zhaoauthor=B.+Wanauthor=X.+Qinauthor=L.+Luauthor=R.+Liauthor=H.+Panauthor=M.+Songauthor=A.+Liuauthor=J.+Hongauthor=H.+Luauthor=J.+Z.+Zhang&title=Crucial+Role+of+Interleukin-7+in+T+Helper+Type+17+Survival+and+Expansion+in+Autoimmune+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease</span></div><div class="casAuthors">Liu, Xuebin; Leung, Stewart; Wang, Chunxia; Tan, Zhu; Wang, Ji; Guo, Taylor B.; Fang, Lei; Zhao, Yonggang; Wan, Bing; Qin, Xia; Lu, Limin; Li, Runsheng; Pan, Heng; Song, Mingjuan; Liu, Ailian; Hong, Jian; Lu, Hongtao; Zhang, Jingwu Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-197</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interleukin-7 receptor (IL-7R) is genetically assocd. with susceptibility to multiple sclerosis.  Here the authors describe that IL-7 is essential for survival and expansion of pathogenic T helper type 17 (TH17) cells in exptl. autoimmune encephalomyelitis (EAE).  IL-7 directly expanded effector TH17 cells in EAE and human TH17 cells from subjects with multiple sclerosis, whereas it was not required for TH17 differentiation.  IL-7R antagonism rendered differentiated TH17 cells susceptible to apoptosis through the inhibition of Janus kinase-signal transducer and activator of transcription-5 (JAK-STAT5) pathway and altered expression of the prosurvival protein Bcl-2 and the proapoptotic protein Bax, leading to decreased severity of EAE.  In contrast, TH1 and regulatory T (Treg) cells were less susceptible to or not affected by IL-7R antagonism in vivo.  The selectivity was attributable to minimal expression of IL-7Rα in Treg cells and correlated with a high level of Socs1 (encoding suppressor of cytokine signaling-1) expression in TH1 cells.  The study reveals a unique, previously undescribed role of IL-7-IL-7R in TH17 cell survival and expansion and has implications in the treatment of autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhIC8NGvTt8rVg90H21EOLACvtfcHk0liVHHcIJe7G_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjsVaqsA%253D%253D&md5=aea9279dec76bfa82e08ea6e7c6c408b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnm.2077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2077%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DT.%2BB.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%2BZ.%26atitle%3DCrucial%2520Role%2520of%2520Interleukin-7%2520in%2520T%2520Helper%2520Type%252017%2520Survival%2520and%2520Expansion%2520in%2520Autoimmune%2520Disease%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D191%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lin, X.; Ren, F.; Zhang, H.</span><span> </span><span class="NLM_article-title">Pyrimidine Derivatives for Use as Sphingosine 1-Phosphate 1 (S1P<sub>1</sub>) Receptor Agonists</span>. WO2011113309(A1),<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=X.+Lin&author=F.+Ren&author=H.+Zhang&title=Pyrimidine+Derivatives+for+Use+as+Sphingosine+1-Phosphate+1+%28S1P1%29+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26atitle%3DPyrimidine%2520Derivatives%2520for%2520Use%2520as%2520Sphingosine%25201-Phosphate%25201%2520%2528S1P1%2529%2520Receptor%2520Agonists%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i44"><a href="/doi/suppl/10.1021/jm2016107">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11765"></div></div></div></div></div><hr /></hr><p class="last">Synthesis procedures and spectral data for compounds <b>3</b>, <b>4a</b>–<b>u</b>, and <b>5a</b>–<b>l</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2016107/suppl_file/jm2016107_si_001.pdf">jm2016107_si_001.pdf (517.94 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm2016107&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-9%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm2016107%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm2016107" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                857KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a92dcd39d1cf","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
